<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome - Martimbianco, ALC - 2017 | Cochrane Library</title> <meta content="Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome - Martimbianco, ALC - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011289.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome - Martimbianco, ALC - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011289.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011289.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome" name="citation_title"/> <meta content="Ana Luiza C Martimbianco" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="analuizacabrera@hotmail.com" name="citation_author_email"/> <meta content="Maria Regina Torloni" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Brenda NG Andriolo" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Gustavo JM Porfírio" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Rachel Riera" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD011289.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/12/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011289.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011289.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011289.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Electric Stimulation Therapy [*methods]; Pain Measurement; Patellofemoral Pain Syndrome [*therapy]; Randomized Controlled Trials as Topic; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011289.pub2&amp;doi=10.1002/14651858.CD011289.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011289\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011289\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011289.pub2",title:"Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome",firstPublishedDate:"Dec 12, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Bone, Joint and Muscle Trauma Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011289.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011289.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011289.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011289.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011289.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011289.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011289.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011289.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011289.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011289.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10239 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011289.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0106"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-sec-0096"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/appendices#CD011289-sec-0111"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/table_n/CD011289StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/table_n/CD011289StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#CD011289-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ana Luiza C Martimbianco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#CD011289-cr-0003">Maria Regina Torloni</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#CD011289-cr-0004">Brenda NG Andriolo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#CD011289-cr-0005">Gustavo JM Porfírio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information#CD011289-cr-0006">Rachel Riera</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information/en#CD011289-sec-0126">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 December 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011289.pub2">https://doi.org/10.1002/14651858.CD011289.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011289-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011289-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011289-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011289-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011289-abs-0001" lang="en"> <section id="CD011289-sec-0001"> <h3 class="title" id="CD011289-sec-0001">Background</h3> <p>Patellofemoral pain syndrome, now generally referred to as patellofemoral pain (PFP), is one of the most common orthopaedic disorders, characterised by pain in the anterior or retropatellar knee region. Neuromuscular electrical stimulation (NMES) has been proposed generally as a complementary treatment, associated with other interventions such as exercise, or as a single treatment to increase muscle force, reduce knee pain, and improve function. </p> </section> <section id="CD011289-sec-0002"> <h3 class="title" id="CD011289-sec-0002">Objectives</h3> <p>To assess the effects (benefits and harms) of neuromuscular electrical stimulation for people with patellofemoral pain. </p> </section> <section id="CD011289-sec-0003"> <h3 class="title" id="CD011289-sec-0003">Search methods</h3> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, PEDro, CINAHL, SPORTDiscus, AMED, LILACS, trial registers, conference abstracts, and reference lists. We carried out the search in May 2017. </p> </section> <section id="CD011289-sec-0004"> <h3 class="title" id="CD011289-sec-0004">Selection criteria</h3> <p>We included randomised controlled clinical trials that evaluated the use of NMES for people with PFP. </p> </section> <section id="CD011289-sec-0005"> <h3 class="title" id="CD011289-sec-0005">Data collection and analysis</h3> <p>Two review authors independently performed the process of study selection, data extraction, and 'Risk of bias' assessment in duplicate. The primary outcomes were knee pain, knee function, and adverse events. The timing of outcome measurements was up to three months (short term), three to 12 months (medium term), and 12 months and above from trial entry (long term). We calculated risk ratios for dichotomous data and mean differences or standardised mean differences for continuous data. Where appropriate, we pooled data using the fixed‐effect model. </p> </section> <section id="CD011289-sec-0006"> <h3 class="title" id="CD011289-sec-0006">Main results</h3> <p>We included eight randomised clinical trials, reporting results for 345 participants with PFP. The mean ages of trial populations ranged from 25 to 43 years, and the majority (53% to 100%) of participants were female. There was a wide duration of symptoms, with the minimum duration of symptoms for trial inclusion ranging from one to six months. In addition to the study inclusion criteria, studies varied widely in the characteristics of the NMES and its application, and associated co‐interventions. We assessed all trials as at high risk of bias in at least one domain, particularly blinding and incomplete outcome data. The results of a laboratory‐based trial reporting knee pain immediately after a single 15‐minute session of NMES are not reported here as these are of questionable clinical relevance. The seven remaining trials provided evidence for three comparisons. We assessed the overall quality of the evidence, using GRADE, for all primary outcomes for all comparisons as very low, thus we are very unsure of the findings. </p> <p>Four studies compared NMES plus exercise versus exercise alone. Patellar taping was applied as well as exercise to all participants of one study, and patellar taping and ice were also applied in another study. Each trial tested a different multiple‐session NMES programme. Pooled data from three studies (118 participants) provided very low‐quality evidence that NMES is associated with reduced pain at the end of treatment (ranging from 3 to 12 weeks): mean difference ‐1.63, 95% confidence interval (CI) ‐2.23 to ‐1.02; visual analogue scale (VAS) 0 to 10; higher scores = worse pain. However, this result may not be clinically relevant since the minimal clinically important difference for VAS during activities (1.5 to 2.0, out of 10 points) lies within the 95% CI. We found very low‐quality evidence from pooled data from two trials of little effect of NMES on knee function, as measured by two knee function rating systems. We found inconclusive and very low‐quality evidence from one trial (29 participants) of little effect of NMES on pain and function at one‐year follow‐up. None of the four trials reported on adverse effects of treatment. </p> <p>One study (94 participants) compared NMES, applied four hours per day on a daily basis for four weeks, with two types of exercises (isometric and isokinetic). The study did not report on knee pain or adverse events. The study provided very low‐quality evidence of no important difference between the two groups in knee function at the end of the four‐week treatment. Of note is the potentially onerous NMES schedule in this study, which does not correspond to that typically used in clinical practice. </p> <p>Two studies compared different types of NMES. Simultaneously delivered high‐low frequencies NMES was compared with sequentially delivered high‐low frequencies NMES in one trial (14 participants) and with fixed frequency NMES in the second trial (64 participants). The studies provided very low‐quality evidence of no important differences at the end of the six‐week treatment programme between the simultaneous frequencies NMES and the two other NMES programmes in overall knee pain, knee function, or in quadriceps fatigue (an adverse event). </p> </section> <section id="CD011289-sec-0007"> <h3 class="title" id="CD011289-sec-0007">Authors' conclusions</h3> <p>This review found insufficient and inconclusive evidence from randomised controlled trials to inform on the role of NMES for treating people with PFP in current clinical practice. The very low‐quality evidence available means that we are uncertain whether or not a multiple‐session programme of NMES combined with exercise over several weeks versus exercise alone results in clinically important differences in knee pain and function at the end of the treatment period or at one year. There were no data on adverse effects such as muscle fatigue and discomfort. High‐quality randomised clinical trials are needed to inform on the use of NMES for people with PFP. However, professional and stakeholder consensus is required on prioritisation of the research questions for interventions for treating people with PFP, including on the NMES treatment protocol for trials testing NMES. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011289-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011289-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011289-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011289-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011289-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011289-abs-0004" lang="en"> <h3>Muscle stimulation for people with anterior knee pain</h3> <p><b>Background</b> </p> <p>Patellofemoral pain syndrome, commonly known as anterior knee pain, is characterised by short‐ or long‐term pain in the front part of the knee or behind the kneecap. Muscle stimulation has been proposed as a treatment for this condition. This involves the use of a device that produces a muscle contraction by placing electrodes on the skin of the leg. Muscle stimulation is often used together with exercises and other treatments but can also be used on its own. </p> <p><b>Results of the search</b> </p> <p>We searched the medical literature up to May 2017 and found eight studies reporting results for a total of 345 participants who had anterior knee pain for at least one month, and sometimes over several years. Most of the participants were female. The average age of participants in the studies ranged from 25 to 43 years. All the studies were small and had flaws that meant they were at risk of bias. There was very little evidence on longer‐term outcome. The results of one study that reported on immediate pain after a single 15‐minute session of muscle stimulation are not reported here as these are of questionable clinical relevance. </p> <p><b>Key results</b> </p> <p>Each of the seven remaining studies tested one of three comparisons.</p> <p>Four studies compared a multiple‐session muscle stimulation programme combined with exercise over several weeks with exercise on its own for the same period. All participants in two studies had adhesive tape applied across their knee cap, with ice also being applied in one study. We found very low‐quality evidence that muscle stimulation with exercise may slightly reduce knee pain at the end of a treatment period of between 3 and 12 weeks better than exercise alone. However, very low‐quality evidence did not show an effect on knee function. None of the studies reported on harms such as muscle fatigue and discomfort. There was very little useful information on longer‐term effects. </p> <p>One study compared muscle stimulation lasting four hours each day for four weeks with exercise. Very low‐quality evidence showed no important difference between the two groups in knee function at the end of the four‐week treatment. Of note is that the duration of muscle stimulation is much longer than used nowadays. </p> <p>Two studies compared different types of muscle stimulation. Very low‐quality evidence showed no important differences at the end of the six‐week treatment programme between the different types of muscle stimulation. </p> <p><b>Quality of the evidence</b> </p> <p>The overall quality of the evidence for all reported outcomes was very low. This means that we are very uncertain about the findings of these studies. </p> <p><b>Conclusions</b> </p> <p>We found insufficient evidence to inform on the role of neuromuscular electrical stimulation for treating people with anterior knee pain. Further research is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011289-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-sec-0106">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-sec-0160">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011289-sec-0106"></div> <h3 class="title" id="CD011289-sec-0107">Implications for practice</h3> <section id="CD011289-sec-0107"> <p>This review found insufficient and inconclusive evidence from randomised trials to inform on the role of neuromuscular electrical stimulation (NMES) for treating people with patellofemoral pain (PFP) in current clinical practice. The very low‐quality evidence available means that we are uncertain whether or not a multiple‐session programme of NMES combined with exercise over several weeks versus exercise alone results in a clinically important difference in knee pain and function at the end of the treatment period or at one year. There were no data on medium‐term outcome (between 3 and up to 12 months) and adverse effects such as muscle fatigue and discomfort. </p> </section> <h3 class="title" id="CD011289-sec-0108">Implications for research</h3> <section id="CD011289-sec-0108"> <p>In addition to insufficient evidence for the use of NMES in people with PFP, we note the absence of a) formal diagnostic criteria for PFP, b) standardisation regarding NMES parameters, and c) definition of priority outcomes. Achieving professional and stakeholder consensus relating to these three aspects, thus on the patient population, the NMES protocol, and outcome assessment, is a key precursor to setting up high‐quality, multicentric randomised clinical trials to remedy the current lack of evidence. Agreement is also required in terms of prioritisation of research on NMES in the context of the known deficiencies in the evidence relating to other interventions for PFP, for example on exercise (<a href="./references#CD011289-bbs2-0051" title="van derHeijdenRA , LankhorstNE , vanLinschotenR , Bierma‐ZeinstraSMA , vanMiddelkoopM . Exercise for treating patellofemoral pain syndrome. Cochrane Database of Systematic Reviews2015, Issue 1. [DOI: 10.1002/14651858.CD010387.pub2] ">van der Heijden 2015</a>), and knee orthoses (<a href="./references#CD011289-bbs2-0049" title="SmithTO , DrewBT , MeekTH , ClarkAB . Knee orthoses for treating patellofemoral pain syndrome. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010513.pub2] ">Smith 2015</a>). In addition to conforming to best‐quality methodological and reporting standards (<a href="./references#CD011289-bbs2-0016" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology2010;63(8):834–40. ">CONSORT 2010</a>), future trials on this topic should assess adverse events related to the intervention, quality of life, and patient satisfaction, and also include both short‐ and long‐term assessment of outcomes, crucially several months after completion of the treatment. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011289-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011289-sec-0029"></div> <div class="table" id="CD011289-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Neuromuscular electrical stimulation + other intervention (e.g. exercise) versus same other intervention only for patellofemoral pain syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Neuromuscular electrical stimulation (NMES) plus other intervention (e.g. exercise) versus no NMES plus same other intervention for patellofemoral pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with patellofemoral pain syndrome<sup>1</sup><br/> <b>Settings:</b> outpatient rehabilitation and home‐based therapy<br/> <b>Intervention:</b> NMES<sup>2</sup> plus other active intervention (e.g. exercise)<sup>3</sup> </p> <p><b>Comparison:</b> no NMES control plus same other active intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No NMES plus same other intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NMES plus other intervention (e.g. exercise)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (short term)<br/> VAS scale: 0 to 10; higher score = worse pain.<br/> Follow‐up: 3 to 12 weeks (all were at the end of the treatment programme<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee pain ranged across control groups from<br/> <b>2.36 to 2.70 points</b>. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee pain in the intervention groups was<br/> <b>1.63 lower</b><br/> (2.23 to 1.02 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.63 (‐2.23 to ‐1.02)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This difference may not be clinically important since the MCID for VAS (1.5 to 2.0, out of 10 points)<sup>5</sup> lies within the 95% CI. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (long term)<br/> VAS scale: 0 to 10; higher score = worse pain.<br/> Follow‐up: 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median pain score in the study control group was <b>0.4 points</b> (IQR 0.2 to 3.4). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median pain score in the NMES group was <b>1.8 points</b> (IQR 0.1 to 3.6). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was reported as not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (short term)<br/> 2 tools used: Cincinnati Knee Rating System (6 to 100; higher scores = better function) and Lower Extremity Functional Scale (LEFS) scale (0 to 80; higher scores = better function).<br/> Follow‐up: 3 to 6 weeks (at the end of the treatment programme) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the study control groups was<br/> <b>72.4</b> (LEFS scale) and <b>83.3</b> (Cincinnati score). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in knee function in the intervention groups was<br/> <b>0.37 SDs higher</b><br/> (0.11 lower to 0.84 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.37 (‐0.11 to 0.84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> <p>However, the mean differences in the 2 trials were small and unlikely to be clinically important (LEFS scale: MD 0.73; Cincinnati score: MD 4.65). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (long term) </p> <p>Kujala Patellofemoral Score (KPS) (0 to 100; higher score = better function).<br/> Follow‐up: 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median KPS in the study control group was <b>95</b> (IQR 85 to 96). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median KPS in the NMES group was <b>94</b> (IQR 88 to 96). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The very small difference was reported as not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not measured </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>MCID:</b> minimal clinically important difference; <b>MD</b> : mean difference; <b>SD:</b> standard deviation; <b>SMD</b> : standardised mean difference; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Where reported, there was a higher percentage of females (63% to 100%). The mean ages of the participants in the four trials ranged from 25 to 39 years. There was a wide duration of symptoms, with the minimum duration of symptoms for trial inclusion ranging from one to six months.<br/> <sup>2</sup>The format of the NMES varied among the four trials. Sessions of NMES lasted between 10 to 20 minutes, applied 2 to 5 times a week, for between 3 and 12 weeks.<br/> <sup>3</sup>The co‐intervention in all four trials was exercise. Patellar taping was also applied to all participants in two trials, and ice was applied in one trial.<br/> <sup>4</sup>We downgraded the evidence two levels due to very serious risk of bias (performance bias), one level for imprecision reflecting small sample size, and one level for indirectness (time point of pain assessment was very far from the end of the intervention).<br/> <sup>5</sup>The minimal clinically important difference for visual analogue scale usual pain was set at 1.5 to 2.0 (out of 10) points (Crossley et al. Archives of Physical Medicine and Rehabilitation 2004;85(5):815‐22).<br/> <sup>6</sup>We downgraded the evidence two levels due to very serious risk of bias (performance, detection, and attrition biases) and two levels for imprecision reflecting single‐trial data and small sample size.<br/> <sup>7</sup>We downgraded the evidence two levels due to very serious risk of bias (performance bias) and one level for imprecision reflecting small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011289-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Neuromuscular electrical stimulation versus exercise for patellofemoral pain syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Neuromuscular electrical stimulation (NMES) versus exercise for patellofemoral pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with patellofemoral pain syndrome<br/> <b>Settings:</b> at home<br/> <b>Intervention:</b> NMES (2‐hour session, twice a day, every day for 4 weeks)<sup>1</sup> </p> <p><b>Comparison:</b> exercise (either isokinetic or isometric; data combined in the analyses) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NMES </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (short term: &lt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (longer term: &gt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b><br/> (short term) <br/> Arpège function scale (0 to 18; higher score = better function).<br/> Follow‐up: 4 weeks (at end of treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the study control group was<br/> <b>15.34 points</b>. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the intervention groups was<br/> <b>0.94 lower</b><br/> (2.1 lower to 0.22 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.94 (‐2.10 to 0.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (longer term: &gt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>MD</b>: mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>This very demanding schedule is unlikely to be found in clinical practice.<br/> <sup>2</sup>We downgraded the evidence two levels for very serious risk of bias (including high risk of performance bias and attrition bias), one level for imprecision (low numbers and wide 95% confidence interval), and one level for indirectness (the scheme used for NMES (during 4 hours/day) does not correspond to that used in clinical practice). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011289-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-sec-0135">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011289-sec-0030"></div> <section id="CD011289-sec-0031"> <h3 class="title" id="CD011289-sec-0031">Description of the condition</h3> <p>Patellofemoral pain syndrome (also known as patella malalignment syndrome, chondromalacia patellae, and anterior knee pain syndrome) is characterised by pain in the anterior or retropatellar (behind the kneecap) knee region that is exacerbated during activities that overload the patellofemoral joint such as running, prolonged sitting, stair climbing, kneeling, or squatting. Additional symptoms of the disorder include reduced muscle strength and knee function (<a href="./references#CD011289-bbs2-0015" title="CollinsNJ , Bierma‐ZeinstraSM , CrossleyKM , vanLinschotenRL , VicenzinoB , vanMiddelkoopM . Prognostic factors for patellofemoral pain: a multicentre observational analysis. British Journal of Sports Medicine2013;47(4):227‐33. ">Collins 2013</a>; <a href="./references#CD011289-bbs2-0039" title="PetersenW , EllermannA , Gösele‐KoppenburgA , BestR , RembitzkiIV , BrüggemannGP , et al. Patellofemoral pain syndrome. Knee Surgery, Sports Traumatology, Arthroscopy 2013 Nov 13 [Epub ahead of print]. [DOI: 10.1007/s00167‐013‐2759‐6] ">Petersen 2013</a>; <a href="./references#CD011289-bbs2-0043" title="RathleffMS , RoosEM , OlesenJL , RasmussenS , Arendt‐NielsenL . Lower mechanical pressure pain thresholds in female adolescents with patellofemoral pain syndrome. Journal of Orthopaedic and Sports Physical Therapy2013;43(6):414‐21. ">Rathleff 2013</a>). In line with the International Patellofemoral Pain consensus statements published in 2014, we now use the term 'patellofemoral pain' (PFP) in this review (<a href="./references#CD011289-bbs2-0056" title="WitvrouwE , CallaghanMJ , StefanikJJ , NoehrenB , Bazett‐JonesDM , WillsonJD , et al. Patellofemoral pain: consensus statement from the 3rd International Patellofemoral Pain Research Retreat held in Vancouver, September 2013. British Journal of Sports Medicine2014;48(6):411‐4. ">Witvrouw 2014</a>). Patellofemoral pain is one of the most common orthopaedic disorders, accounting for 25% to 40% of all sports‐related knee problems; it predominantly affects adolescents and young adults, especially physically active women (<a href="./references#CD011289-bbs2-0023" title="FaganV , DelahuntE . Patellofemoral pain syndrome: a review on the associated neuromuscular deficits and current treatment options. British Journal of Sports Medicine2008;42(10):489‐95. ">Fagan 2008</a>; <a href="./references#CD011289-bbs2-0024" title="FryeJL , RameyLN , HartJM . The effects of exercise on decreasing pain and increasing function in patients with patellofemoral pain syndrome: a systematic review. Sports Health2012;4(3):205‐10. ">Frye 2012</a>). The prevalence of PFP is higher in active populations, including athletes and military recruits, than in the general population. However, the prevalence of this disorder in unselected populations is unclear (<a href="./references#CD011289-bbs2-0030" title="LankhorstNE , Bierma‐ZeinstraSM , vanMiddelkoopM . Risk factors for patellofemoral pain syndrome: a systematic review. Journal of Orthopaedic and Sports Physical Therapy2012;42(2):81‐94. ">Lankhorst 2012</a>; <a href="./references#CD011289-bbs2-0039" title="PetersenW , EllermannA , Gösele‐KoppenburgA , BestR , RembitzkiIV , BrüggemannGP , et al. Patellofemoral pain syndrome. Knee Surgery, Sports Traumatology, Arthroscopy 2013 Nov 13 [Epub ahead of print]. [DOI: 10.1007/s00167‐013‐2759‐6] ">Petersen 2013</a>; <a href="./references#CD011289-bbs2-0046" title="RoushJR , Curtis BayR . Prevalence of anterior knee pain in 18‐35 year‐old females. International Journal of Sports Physical Therapy2012;7(4):396‐401. ">Roush 2012</a>). </p> <p>The aetiology of PFP is multifactorial. Common causes include mechanical and structural changes in the patellofemoral joint, malalignment of the patella (also known as patella maltracking), weakness of the knee extensor muscles (quadriceps musculature), poor muscle flexibility, and altered lower extremity kinematics (<a href="./references#CD011289-bbs2-0013" title="BolglaLA , BolingMC . An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. International Journal of Sports Physical Therapy2011;6(2):112‐25. ">Bolgla 2011</a>; <a href="./references#CD011289-bbs2-0030" title="LankhorstNE , Bierma‐ZeinstraSM , vanMiddelkoopM . Risk factors for patellofemoral pain syndrome: a systematic review. Journal of Orthopaedic and Sports Physical Therapy2012;42(2):81‐94. ">Lankhorst 2012</a>; <a href="./references#CD011289-bbs2-0040" title="PowersCM . The influence of altered lower‐extremity kinematics on patellofemoral joint dysfunction: a theoretical perspective. Journal of Orthopaedic and Sports Physical Therapy2003;33(11):639‐46. ">Powers 2003</a>). There are no specific diagnostic tests for PFP, and the diagnosis is usually based on clinical symptoms and physical examination (<a href="./references#CD011289-bbs2-0018" title="CrossleyK , BennellK , GreenS , CowanS , McConnellJ . Physical therapy for patellofemoral pain: a randomized, double‐blinded, placebo‐controlled trial. American Journal of Sports Medicine2002;30(6):857‐65. ">Crossley 2002</a>; <a href="./references#CD011289-bbs2-0046" title="RoushJR , Curtis BayR . Prevalence of anterior knee pain in 18‐35 year‐old females. International Journal of Sports Physical Therapy2012;7(4):396‐401. ">Roush 2012</a>). </p> <p>It is widely believed that patellofemoral malalignment is the primary mechanism responsible for anterior knee pain. Since the patella acts as a lever for the knee extensor muscles, any changes in the angle of the knee will also affect the peak force of the quadriceps (<a href="./references#CD011289-bbs2-0013" title="BolglaLA , BolingMC . An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. International Journal of Sports Physical Therapy2011;6(2):112‐25. ">Bolgla 2011</a>; <a href="./references#CD011289-bbs2-0041" title="PowersCM , BolglaLA , CallaghanMJ , CollinsN , SheehanFT . Patellofemoral pain: proximal, distal, and local factors, 2nd International Research Retreat. Journal of Orthopaedic and Sports Physical Therapy2012;42(6):A1‐54. ">Powers 2012</a>). Recent studies have shown that the patella of people with PFP tends to deviate laterally within the femoral trochlear groove to a greater extent than normal during knee movement, leading to both a decrease in the patellofemoral contact area and an increase in the pressure on the articular surface, thus resulting in peripatellar tissue inflammation and pain (<a href="./references#CD011289-bbs2-0026" title="KayaD , CitakerS , KerimogluU , AtayOA , NylandJ , CallaghanM , et al. Women with patellofemoral pain syndrome have quadriceps femoris volume and strength deficiency. Knee Surgery, Sports Traumatology, Arthroscopy2011;19(2):242‐7. ">Kaya 2011</a>; <a href="./references#CD011289-bbs2-0041" title="PowersCM , BolglaLA , CallaghanMJ , CollinsN , SheehanFT . Patellofemoral pain: proximal, distal, and local factors, 2nd International Research Retreat. Journal of Orthopaedic and Sports Physical Therapy2012;42(6):A1‐54. ">Powers 2012</a>; <a href="./references#CD011289-bbs2-0047" title="SalsichGB , BrechterJH , PowersCM . Lower extremity kinetics during stair ambulation. Clinical Biomechanics2001;16:906‐12. ">Salsich 2001</a>). </p> <p>Several factors, including large quadriceps angle, abnormalities of the patellofemoral joint, excessive foot pronation, and tightness of hamstrings, calf, and lateral retinaculum can lead to abnormal patellar gliding (<a href="./references#CD011289-bbs2-0012" title="BartonCJ , LevingerP , MenzHB , WebsterKE . Kinematic gait characteristics associated with patellofemoral pain syndrome: a systematic review. Gait &amp; Posture2009;30(4):405‐16. ">Barton 2009</a>; <a href="./references#CD011289-bbs2-0020" title="DaviesAP , CostaML , ShepstoneL , GlasgowMM , DonellS . The sulcus angle and malalignment of the extensor mechanism of the knee. Journal of Bone and Joint Surgery ‐ British Volume2000;82(B):1162‐6. ">Davies 2000</a>; <a href="./references#CD011289-bbs2-0023" title="FaganV , DelahuntE . Patellofemoral pain syndrome: a review on the associated neuromuscular deficits and current treatment options. British Journal of Sports Medicine2008;42(10):489‐95. ">Fagan 2008</a>; <a href="./references#CD011289-bbs2-0037" title="PalS , BesierTF , DraperCE , FredericsonM , GoldGE , BeaupreGS , et al. Patellar tilt correlates with vastus lateralis: vastus medialis activation ratio in maltracking patellofemoral pain patients. Journal of Orthopaedic Research2012;30(6):927‐33. ">Pal 2012</a>). However, according to biomechanical studies, hip muscle weakness and decreased quadriceps torque (especially the imbalance between activation of the vastus lateralis (VL) and vastus medialis oblique (VMO) muscles) are the main causes of patellar maltracking and patellofemoral pain (<a href="./references#CD011289-bbs2-0014" title="ChiuJK , WongYM , YungPS , NgGY . The effects of quadriceps strengthening on pain, function, and patellofemoral joint contact area in persons with patellofemoral pain. American Journal of Physical Medicine &amp; Rehabilitation2012;91(2):98‐106. ">Chiu 2012</a>; <a href="./references#CD011289-bbs2-0017" title="CowanSM , CrossleyKM , BennellKL . Altered hip and trunk muscle function in individuals with patellofemoral pain. British Journal of Sports Medicine2009;43(8):584‐8. ">Cowan 2009</a>; <a href="./references#CD011289-bbs2-0037" title="PalS , BesierTF , DraperCE , FredericsonM , GoldGE , BeaupreGS , et al. Patellar tilt correlates with vastus lateralis: vastus medialis activation ratio in maltracking patellofemoral pain patients. Journal of Orthopaedic Research2012;30(6):927‐33. ">Pal 2012</a>; <a href="./references#CD011289-bbs2-0039" title="PetersenW , EllermannA , Gösele‐KoppenburgA , BestR , RembitzkiIV , BrüggemannGP , et al. Patellofemoral pain syndrome. Knee Surgery, Sports Traumatology, Arthroscopy 2013 Nov 13 [Epub ahead of print]. [DOI: 10.1007/s00167‐013‐2759‐6] ">Petersen 2013</a>). </p> <p>The response of people with PFP to conservative (non‐surgical) interventions such as physical therapy (including patellar taping, joint mobilisation, quadriceps strengthening, and foot orthoses, among others) and analgesic medications is variable. Long‐term results are not always satisfactory, and therefore the disorder can become chronic (<a href="./references#CD011289-bbs2-0038" title="PattynE , MahieuN , SelfeJ , VerdonkP , SteyaertA , WitvrouwE . What predicts functional outcome after treatment for patellofemoral pain?. Medicine and Science in Sports Exercise2012;44(10):1827‐33. ">Pattyn 2012</a>; <a href="./references#CD011289-bbs2-0042" title="RathleffMS , RoosEM , OlesenJL , RasmussenS . Early intervention for adolescents with patellofemoral pain syndrome ‐ a pragmatic cluster randomised controlled trial. BMC Musculoskeletal Disorders2012;27(13):1‐9. [DOI: 10.1186/1471‐2474‐13‐9] ">Rathleff 2012</a>). A recent study showed that approximately half of treated patients reported persistent symptoms after 12 months (<a href="./references#CD011289-bbs2-0015" title="CollinsNJ , Bierma‐ZeinstraSM , CrossleyKM , vanLinschotenRL , VicenzinoB , vanMiddelkoopM . Prognostic factors for patellofemoral pain: a multicentre observational analysis. British Journal of Sports Medicine2013;47(4):227‐33. ">Collins 2013</a>). Factors that may be associated with poor prognosis include higher age, female gender, overweight, reduced muscle strength, sports participation (overuse of the patellofemoral joint), and duration of symptoms over two months (<a href="./references#CD011289-bbs2-0015" title="CollinsNJ , Bierma‐ZeinstraSM , CrossleyKM , vanLinschotenRL , VicenzinoB , vanMiddelkoopM . Prognostic factors for patellofemoral pain: a multicentre observational analysis. British Journal of Sports Medicine2013;47(4):227‐33. ">Collins 2013</a>; <a href="./references#CD011289-bbs2-0038" title="PattynE , MahieuN , SelfeJ , VerdonkP , SteyaertA , WitvrouwE . What predicts functional outcome after treatment for patellofemoral pain?. Medicine and Science in Sports Exercise2012;44(10):1827‐33. ">Pattyn 2012</a>; <a href="./references#CD011289-bbs2-0042" title="RathleffMS , RoosEM , OlesenJL , RasmussenS . Early intervention for adolescents with patellofemoral pain syndrome ‐ a pragmatic cluster randomised controlled trial. BMC Musculoskeletal Disorders2012;27(13):1‐9. [DOI: 10.1186/1471‐2474‐13‐9] ">Rathleff 2012</a>). Those prognostic factors indicate that early diagnosis and treatment may lead to better long‐term results (<a href="./references#CD011289-bbs2-0042" title="RathleffMS , RoosEM , OlesenJL , RasmussenS . Early intervention for adolescents with patellofemoral pain syndrome ‐ a pragmatic cluster randomised controlled trial. BMC Musculoskeletal Disorders2012;27(13):1‐9. [DOI: 10.1186/1471‐2474‐13‐9] ">Rathleff 2012</a>). </p> </section> <section id="CD011289-sec-0032"> <h3 class="title" id="CD011289-sec-0032">Description of the intervention</h3> <p>Exercise therapy has been highly regarded as an essential tool in the treatment of people with PFP (<a href="./references#CD011289-bbs2-0042" title="RathleffMS , RoosEM , OlesenJL , RasmussenS . Early intervention for adolescents with patellofemoral pain syndrome ‐ a pragmatic cluster randomised controlled trial. BMC Musculoskeletal Disorders2012;27(13):1‐9. [DOI: 10.1186/1471‐2474‐13‐9] ">Rathleff 2012</a>). According to several clinical trials, muscle‐strengthening exercises help to correct abnormal patellar alignment and reduce clinical symptoms such as pain and impaired function (<a href="./references#CD011289-bbs2-0013" title="BolglaLA , BolingMC . An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. International Journal of Sports Physical Therapy2011;6(2):112‐25. ">Bolgla 2011</a>; <a href="./references#CD011289-bbs2-0014" title="ChiuJK , WongYM , YungPS , NgGY . The effects of quadriceps strengthening on pain, function, and patellofemoral joint contact area in persons with patellofemoral pain. American Journal of Physical Medicine &amp; Rehabilitation2012;91(2):98‐106. ">Chiu 2012</a>; <a href="./references#CD011289-bbs2-0018" title="CrossleyK , BennellK , GreenS , CowanS , McConnellJ . Physical therapy for patellofemoral pain: a randomized, double‐blinded, placebo‐controlled trial. American Journal of Sports Medicine2002;30(6):857‐65. ">Crossley 2002</a>; <a href="./references#CD011289-bbs2-0024" title="FryeJL , RameyLN , HartJM . The effects of exercise on decreasing pain and increasing function in patients with patellofemoral pain syndrome: a systematic review. Sports Health2012;4(3):205‐10. ">Frye 2012</a>). However, in some people, exercise can exacerbate pain and inflammation and reduce voluntary muscle activation (<a href="./references#CD011289-bbs2-0022" title="DyeSF . The pathophysiology of patellofemoral pain: a tissue homeostasis perspective. Clinical Orthopaedics and Related Research2005;436:100‐10. ">Dye 2005</a>). Neuromuscular electrical stimulation (NMES) has been proposed as a complementary treatment, associated with other interventions such as voluntary exercise, or as a single treatment to increase muscle force by activating motor units and promoting muscle contraction (<a href="./references#CD011289-bbs2-0029" title="LakeDA , WoffordNH . Effect of therapeutic modalities on patients with patellofemoral pain syndrome: a systematic review. Sports Health2011;3(2):182‐9. ">Lake 2011</a>; <a href="./references#CD011289-bbs2-0036" title="MonaghanB , CaulfieldB , O’MathúnaDP . Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007177.pub2] ">Monaghan 2010</a>; <a href="./references#CD011289-bbs2-0050" title="TaradajJ , HalskiT , KucharzewskiM , WalewiczK , SmyklaA , OzonM , et al. The effect of neuromuscular electrical stimulation on quadriceps strength and knee function in professional soccer players: return to sport after ACL reconstruction. Biomed Research International 2013 Dec 5 [Epub ahead of print]. [DOI: 10.1155/2013/802534] ">Taradaj 2013</a>). </p> <p>Electrical stimulation is produced by a device that delivers intermittent electrical impulses to muscle fibres through electrodes placed on the skin. These impulses induce action potentials, which stimulate motor nerves, thus producing contractions (<a href="./references#CD011289-bbs2-0021" title="DoucetBM , LamA , GriffinL . Neuromuscular electrical stimulation for skeletal muscle function. Yale Journal of Biology and Medicine2012;85(2):201‐15. ">Doucet 2012</a>). These parameters include: frequency (usually set between 50 to 70 Hz); pulse (monophasic or biphasic, in waveform geometrical patterns such as rectangular); pulse duration (between 1 to 1000 µs, most often between 100 to 400 µs); duty cycle/duration of muscle contraction (intermittent pulse stimulation, i.e. pulses on and off, usually set as 10 seconds on and 50 seconds off); and intensity (adjusted according to individual tolerance) (<a href="./references#CD011289-bbs2-0021" title="DoucetBM , LamA , GriffinL . Neuromuscular electrical stimulation for skeletal muscle function. Yale Journal of Biology and Medicine2012;85(2):201‐15. ">Doucet 2012</a>; <a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>; <a href="./references#CD011289-bbs2-0048" title="SillenMJ , FranssenFM , GoskerHR , WoutersEF , SpruitMA . Metabolic and structural changes in lower‐limb skeletal muscle following neuromuscular electrical stimulation: a systematic review. PLoS ONE2013;8(9):e69391. ">Sillen 2013</a>). When comparing an NMES group with a control or a placebo group (e.g. NMES parameters configured not to produce muscle contraction), there is a significant increase in quadriceps muscle strength in people who receive active NMES (<a href="./references#CD011289-bbs2-0033" title="MaddocksM , GaoW , HigginsonIJ , WilcockA . Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD009419.pub2] ">Maddocks 2013</a>). </p> <p>Although there is still no consensus on the standardisation of optimal NMES parameters, some studies suggest that electrical stimulation should be able to produce 50% of maximal voluntary contraction and recommend the use of biphasic rectangular pulses of 100 to 400 microseconds delivered at 50 to 100 Hz, at the highest tolerated intensity. The usual treatment for quadriceps muscles involves two or more sessions per week, 10 to 30 minutes each, for a period of four to five months (<a href="./references#CD011289-bbs2-0048" title="SillenMJ , FranssenFM , GoskerHR , WoutersEF , SpruitMA . Metabolic and structural changes in lower‐limb skeletal muscle following neuromuscular electrical stimulation: a systematic review. PLoS ONE2013;8(9):e69391. ">Sillen 2013</a>; <a href="./references#CD011289-bbs2-0052" title="VanderthommenM , DuchateauJ . Electrical stimulation as a modality to improve performance of the neuromuscular system. Exercise and Sport Sciences Review2007;35(4):180‐5. ">Vanderthommen 2007</a>). </p> <p>The main adverse effects of NMES are muscular discomfort caused by the electrical stimuli and excessive neuromuscular fatigue, which can be reduced by adjusting the NMES parameters (<a href="./references#CD011289-bbs2-0035" title="MaffiulettiNA , VivodtzevI , MinettoMA , PlaceN . A new paradigm of neuromuscular electrical stimulation for the quadriceps femoris muscle. European Journal of Applied Physiology2014;114(6):1197‐205. [DOI: 10.1007/s00421‐014‐2849‐2] ">Maffiuletti 2014</a>). Furthermore, the use of NMES over the thoracic region can cause changes in cardiac rhythm, therefore this intervention is not recommended for people with hypertension or those using pacemakers (<a href="./references#CD011289-bbs2-0021" title="DoucetBM , LamA , GriffinL . Neuromuscular electrical stimulation for skeletal muscle function. Yale Journal of Biology and Medicine2012;85(2):201‐15. ">Doucet 2012</a>; <a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>; <a href="./references#CD011289-bbs2-0036" title="MonaghanB , CaulfieldB , O’MathúnaDP . Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007177.pub2] ">Monaghan 2010</a>). </p> </section> <section id="CD011289-sec-0033"> <h3 class="title" id="CD011289-sec-0033">How the intervention might work</h3> <p>Researchers report the use of NMES in people with PFP to strengthen the quadriceps muscles in general and also to selectively strengthen the VMO muscle in cases where this muscle is hypotrophic and contracting after the VL muscle (<a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>; <a href="./references#CD011289-bbs2-0055" title="WernerS , ArvidssonH , ArvidssonI , ErikssonE . Electrical stimulation of vastus medialis and stretching of lateral thigh muscles in patients with patello‐femoral symptoms. Knee Surgery, Sports Traumatology, Arthroscopy1993;1(2):85‐92. ">Werner 1993</a>). Because NMES promotes simultaneous VMO and VL muscle contractions, it apparently leads to a significant increase in quadriceps muscles' force (<a href="./references#CD011289-bbs2-0053" title="VengustR , StrojnikV , PavlovcicV , AntolicV , ZupancO . The effect of electrostimulation and high load exercises in patients with patellofemoral joint dysfunction. A preliminary report. European Journal of Physiology2001;442(6):153‐4. ">Vengust 2001</a>; <a href="./references#CD011289-bbs2-0055" title="WernerS , ArvidssonH , ArvidssonI , ErikssonE . Electrical stimulation of vastus medialis and stretching of lateral thigh muscles in patients with patello‐femoral symptoms. Knee Surgery, Sports Traumatology, Arthroscopy1993;1(2):85‐92. ">Werner 1993</a>). </p> <p>Good results also depend on using electrodes of appropriate size and their adequate positioning (<a href="./references#CD011289-bbs2-0021" title="DoucetBM , LamA , GriffinL . Neuromuscular electrical stimulation for skeletal muscle function. Yale Journal of Biology and Medicine2012;85(2):201‐15. ">Doucet 2012</a>; <a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>). Since the electric current produced by NMES is superficial, stimulation delivered is not sufficient to recruit a large number of motor units and produce an effective muscle contraction, therefore the characteristics and the spatial position of surface electrodes can influence the effectiveness of the muscle contraction. Despite the lack of a standard procedure, electrodes are often used in pairs of the same size, placed side by side over the muscle (<a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>; <a href="./references#CD011289-bbs2-0048" title="SillenMJ , FranssenFM , GoskerHR , WoutersEF , SpruitMA . Metabolic and structural changes in lower‐limb skeletal muscle following neuromuscular electrical stimulation: a systematic review. PLoS ONE2013;8(9):e69391. ">Sillen 2013</a>; <a href="./references#CD011289-bbs2-0052" title="VanderthommenM , DuchateauJ . Electrical stimulation as a modality to improve performance of the neuromuscular system. Exercise and Sport Sciences Review2007;35(4):180‐5. ">Vanderthommen 2007</a>). Some authors have shown that the use of multiple electrodes, of large size, produces better results in muscle strengthening and reduction of discomfort, presumably due to the wide distribution and greater intensity of the electrical current. Additionally, gradual increase of the NMES intensity is recommended in order to activate deep muscle fibres and optimise muscle contraction (<a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>; <a href="./references#CD011289-bbs2-0035" title="MaffiulettiNA , VivodtzevI , MinettoMA , PlaceN . A new paradigm of neuromuscular electrical stimulation for the quadriceps femoris muscle. European Journal of Applied Physiology2014;114(6):1197‐205. [DOI: 10.1007/s00421‐014‐2849‐2] ">Maffiuletti 2014</a>). </p> </section> <section id="CD011289-sec-0034"> <h3 class="title" id="CD011289-sec-0034">Why it is important to do this review</h3> <p>Neuromuscular electrical stimulation is currently widely used by physical therapists to treat people with several types of knee problems and in postoperative rehabilitation; however, the effectiveness of NMES for PFP remains uncertain. Through a critical summary of the evidence for NMES for treating PFP, this review aims to help health professionals and patients make informed clinical decisions about treatment choices for PFP and identify research gaps in this area in relation to NMES. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011289-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-sec-0140">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011289-sec-0035"></div> <p>To assess the effects (benefits and harms) of neuromuscular electrical stimulation for people with patellofemoral pain. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011289-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-sec-0141">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011289-sec-0036"></div> <section id="CD011289-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011289-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled clinical trials evaluating the use of NMES for people with PFP. </p> </section> <section id="CD011289-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included studies involving adolescents and adults diagnosed with PFP. We excluded studies of participants with patellar luxation, patellar fracture, osteoarthritis, or other intra‐articular knee pathology. We excluded studies that included a mixed population where a percentage of the participants had some other knee pathology or were children, unless the results of people with PFP were presented separately or the proportion of those with other knee pathology or children was small (less than 5%) and preferably balanced between groups. </p> </section> <section id="CD011289-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing any kind of NMES with:</p> <p> <ul id="CD011289-list-0001"> <li> <p>placebo or sham intervention (e.g. stimulation parameters below the level required to promote muscle contraction or no stimulator output); </p> </li> <li> <p>no treatment;</p> </li> <li> <p>exercise.</p> </li> </ul> </p> <p>We also included trials comparing different programmes of NMES (e.g. different frequencies, intensity, and duration). For these comparisons, we designated the control group to be the one with a lower frequency, less intensive, or shorter duration programme. </p> <p>We included studies that tested NMES as an isolated procedure or in combination with other conservative interventions (e.g. exercise programme), as long as the same intervention was also offered to people in the control group. </p> </section> <section id="CD011289-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD011289-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011289-list-0002"> <li> <p>Knee pain (measured by validated pain scores, such as visual analogue scales (VAS)) (<a href="./references#CD011289-bbs2-0044" title="RevillSI , RobinsonJO , RosenM , HoggMI . The reliability of a linear analogue for evaluating pain. Anaesthesia1976;31(9):1191‐8. ">Revill 1976</a>). </p> </li> <li> <p>Knee function measured by validated knee questionnaires (such as Kujala Patellofemoral Score and Lysholm score) (<a href="./references#CD011289-bbs2-0028" title="KujalaUM , JaakkolaLH , KoskinenSK , TaimelaS , HurmeM , NelimarkkaO . Scoring of patellofemoral disorders. Arthroscopy1993;9(2):159‐63. ">Kujala 1993</a>; <a href="./references#CD011289-bbs2-0032" title="LysholmJ , GillquistJ . Evaluation of the knee ligament surgery results with special emphasis on use of a scoring scale. American Journal of Sports Medicine1982;10(3):150‐4. ">Lysholm 1982</a>). </p> </li> <li> <p>Adverse events (e.g. skin injuries, excessive discomfort, excessive fatigue, bradycardia or other cardiac arrhythmia, or substantially increased pain as a direct effect of treatment). </p> </li> </ol> </p> </section> <section id="CD011289-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011289-list-0003"> <li> <p>Objectively measured performance tests (such as hop test, timed up‐and‐go, stair climbing).</p> </li> <li> <p>Health‐related quality of life (measured by validated assessment tools such as Medical Outcomes Study 36‐item short‐form health survey (SF‐36) for general measures) (<a href="./references#CD011289-bbs2-0054" title="WareJEJr , SherbourneCD . The MOS 36‐item short‐form health survey (SF‐36) I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>). </p> </li> <li> <p>Participant satisfaction (preferably measured by validated assessment tools).</p> </li> <li> <p>Muscle strength (directly measured, e.g. by isokinetic dynamometer).</p> </li> </ol> </p> <p>We did not consider trials where muscle strength or outcome measures such as EMG (electromyogram) data and gait analysis were studied without evaluation of pain or knee function. </p> <section id="CD011289-sec-0044"> <h6 class="title">Timing of outcome measurement</h6> <p>We adjusted the previous criteria subsequent to external referee's feedback (see <a href="#CD011289-sec-0130">Differences between protocol and review</a>). This included starting the follow‐up at trial entry. </p> <p> <ul id="CD011289-list-0004"> <li> <p>Up to three months (short term); this coincided with the end of the treatment programme in all trials </p> </li> <li> <p>Three to up to 12 months (medium term)</p> </li> <li> <p>12 months or over (long term)</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD011289-sec-0045"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011289-sec-0046"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (9 May 2017), the Cochrane Central Register of Controlled Trials (CENTRAL) (2017; Issue 5), Ovid MEDLINE (including MEDLINE In‐Process &amp; Other Non‐Indexed Citations, MEDLINE Daily and Epub Ahead of Print) (1946 to 5 May 2017), Embase (Ovid Online) (1974 to 2017 Week 18), the Physiotherapy Evidence Database (PEDro) (1999 to 15 July 2016), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO) (1982 to 5 May 2017), SPORTDiscus (EBSCO) (1985 to 5 May 2017), Allied and Complementary Medicine Database (AMED) (Ovid Online) (1985 to 5 May 2017), and Latin American and Caribbean Health Sciences (LILACS) (BIREME) (1982 to 5 May 2017). We also searched the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>), and the ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>) for ongoing trials (5 May 2017). We did not apply any restrictions based on publication status or language. </p> <p>In MEDLINE (Ovid Online), the subject specific strategy was combined with the sensitivity‐maximising version of the Cochrane Highly Sensitive Search Strategy for identifying randomised trials (<a href="./references#CD011289-bbs2-0031" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). The search strategies for all databases are reported in <a href="./appendices#CD011289-sec-0112">Appendix 1</a>. </p> </section> <section id="CD011289-sec-0047"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of relevant studies and conference abstracts of the International Patellofemoral Pain Research Retreat (IPRR) (<a href="https://ipfrn.org/conference/" target="_blank">ipfrn.org/conference/</a>) (from 2009 to 2013) and the International Patellofemoral Pain Clinical Symposium (<a href="https://ipfrn.org/clinicalsymposium/" target="_blank">ipfrn.org/clinicalsymposium/</a>) (2013). We also contacted experts in the field to identify published, unpublished, or ongoing trials. </p> </section> </section> <section id="CD011289-sec-0048"> <h3 class="title" id="CD011289-sec-0048">Data collection and analysis</h3> <p>We carried out data collection and analysis according to the methods stated in the published protocol (<a href="./references#CD011289-bbs2-0057" title="MartimbiancoALC , TorloniMR , AndrioloBNG , PorfirioG , RieraR . Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD011289] ">Martimbianco 2014</a>). </p> <section id="CD011289-sec-0049"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ALCM and GP) independently screened the titles and abstracts retrieved through the search strategy. The full texts of all studies considered potentially eligible for inclusion were retrieved and read independently by the two review authors for final selection. Disagreements were settled by a third author (RR). </p> </section> <section id="CD011289-sec-0050"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (ALCM and GP) independently extracted the data from all reports of the included studies using a piloted extraction form that included information on participant characteristics, methodological aspects, interventions, comparisons, outcomes, follow‐up, and results. Unresolved disagreements between the two review authors were settled by a third review author (RR). We attempted to contact trial authors for clarification and additional information when necessary. </p> </section> <section id="CD011289-sec-0051"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ALCM and BNGA) independently assessed the risk of bias in the included studies using the Cochrane 'Risk of bias' tool (<a href="./references#CD011289-bbs2-0025" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), which assesses seven domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete outcome data, selective reporting, and other sources of bias. Regarding this last domain we looked for major baseline imbalance as a potential cause of bias. We judged each of the seven domains as being at high, low, or unclear risk of bias. Disagreements between the two review authors were settled by a third review author (RR). </p> </section> <section id="CD011289-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated risk ratios (RR) with 95% confidence intervals (95% CI) for dichotomous data and mean differences (MD) with 95% CIs for continuous data. In cases where different scales were used to measure the same outcome, we planned to use standardised mean differences (SMD) with 95% CIs. </p> </section> <section id="CD011289-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>As we expected, the unit of randomisation in the included trials was the individual participant. In future updates of this review, if we find studies in which the unit of analysis is the knee rather than the individual participant, and where corrections have not been made, we will consider presenting the data for the trials where the disparity between the units of analysis and randomisation is small. Had we found studies with cross‐over designs, we would have considered the first stage as indicated in our protocol. We avoided unit of analysis issues related to repeated observations of the same outcome. For example, where trial results were presented for several periods of follow‐up, we presented data for these separately according to the different follow‐up periods defined in <a href="#CD011289-sec-0041">Types of outcome measures</a>. </p> </section> <section id="CD011289-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors to obtain any missing data and information. Where we were successful, we recorded the date of communication and the information obtained. We planned to conduct intention‐to‐treat analyses whenever possible. If necessary and possible, for continuous data we planned to calculate missing standard deviations (SDs) from exact P values, 95% CIs, or standard errors. </p> </section> <section id="CD011289-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity by visual inspection of forest plots and by using the I<sup>2</sup> statistic, as recommended by <a href="./references#CD011289-bbs2-0025" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>: 0% to 40% indicated no significant heterogeneity; 30% to 60% indicated moderate heterogeneity; 50% to 90% could represent substantial heterogeneity; and 75% to 100% was indicative of very substantial heterogeneity. We also used the Chi<sup>2</sup> test: statistical significance (P &lt; 0.1) was interpreted as significant heterogeneity. </p> </section> <section id="CD011289-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are at least 10 studies in a meta‐analysis of any primary outcome, we intend to perform a funnel plot to explore potential publication bias. </p> </section> <section id="CD011289-sec-0057"> <h4 class="title">Data synthesis</h4> <p>When considered appropriate and where data were available, we pooled the results of comparable groups of trials using the fixed‐effect or random‐effects analysis models. Our choice of the fixed‐effect model for reporting purposes was guided by a careful consideration of the extent of heterogeneity and whether it could be explained, in addition to other factors such as the number and size of the included studies. We planned not to pool data where there was considerable heterogeneity (I<sup>2</sup> &gt; 75%) that could not be explained by differences in methodological or clinical features among the trials. Where it was not appropriate to pool data, we presented trial data in the analyses for illustrative purposes and reported these in the text. </p> </section> <section id="CD011289-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses: according to control group intervention (placebo versus no NMES control); when NMES was the main intervention or a complementary or auxiliary intervention; age of participants (18 years or more versus less than 18 years); gender; physical activity level (athletic, i.e. regular sports participation, versus non‐athletic); and duration of PFP symptoms (acute, i.e. less than three months, versus chronic). However, subgroup analysis was not possible because data were insufficient. In future updates, if sufficient data are available, we will perform subgroup analysis to investigate whether the results of subgroups were significantly different by inspecting the overlap of CIs and by performing the test for subgroup differences available in Review Manager 5 (<a href="./references#CD011289-bbs2-0045" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD011289-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>In future updates of this review, if sufficient trials are available, we plan to perform sensitivity analyses examining various aspects of trial and review methodology, including: the effects of missing data; of excluding trials at high or unclear risk of bias (specifically, selection bias from lack of allocation concealment, and detection bias from lack of outcome assessor blinding); trials only reported in abstracts; trials with unit of analysis problems related to the inclusion of participants with bilateral PFP; and the selection of the statistical model (fixed‐effect versus random‐effects). We also plan to examine the effect of including trials that provide suboptimal dosing: less than two sessions per week, lasting under 15 minutes each, for less than two weeks (<a href="./references#CD011289-bbs2-0021" title="DoucetBM , LamA , GriffinL . Neuromuscular electrical stimulation for skeletal muscle function. Yale Journal of Biology and Medicine2012;85(2):201‐15. ">Doucet 2012</a>; <a href="./references#CD011289-bbs2-0034" title="MaffiulettiNA . Physiological and methodological considerations for the use of neuromuscular electrical stimulation. European Journal of Applied Physiology2010;110(2):223‐34. ">Maffiuletti 2010</a>). </p> <section id="CD011289-sec-0060"> <h5 class="title">Assessing the quality of the evidence and presenting 'Summary of findings' tables</h5> <p>We assessed the quality of the evidence for the primary outcomes (pain, function, and adverse events) according to the GRADE approach per Section 12.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011289-bbs2-0025" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We prepared two 'Summary of findings' tables for the following comparisons: NMES plus other intervention (e.g. exercise) versus no NMES plus same other intervention; and NMES versus exercise. We presented knee pain and knee function at end of treatment (short term) and in the longer term (three months or above) and adverse events. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011289-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011289-sec-0061"></div> <section id="CD011289-sec-0062"> <h3 class="title">Description of studies</h3> <section id="CD011289-sec-0063"> <h4 class="title">Results of the search</h4> <p>We retrieved a total of 340 records from the following databases: Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (5); CENTRAL (21), MEDLINE (47), Embase (123), PEDro (19), CINAHL (29), SPORTDiscus (14), AMED (16), LILACS (9), the WHO International Clinical Trials Registry Platform (11), ClinicalTrials.gov (44), and the ISRCTN registry (2). After excluding 87 duplicates, we screened 253 citations and excluded 241 that were not relevant. We judged 12 reports to be potentially eligible, which we selected for full‐text reading. Eight studies (nine reports) met our selection criteria and were included in the review (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> (two reports); <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). We excluded two studies (<a href="./references#CD011289-bbs2-0009" title="DursunN , DursunE , KiliçZ . Electromyographic biofeedback–controlled exercise versus conservative care for patellofemoral pain syndrome. Archives of Physical Medicine and Rehabilitation2001;82:1692‐5. ">Dursun 2001</a>; <a href="./references#CD011289-bbs2-0010" title="KuruT , YalimanA , DereliEE . Comparison of efficiency of Kinesio taping and electrical stimulation in patients with patellofemoral pain syndrome. Acta Orthopaedica et Traumatologica Turcica2012;46(5):385‐92. ">Kuru 2012</a>), and identified one ongoing study from our search of ClinicalTrials.gov (<a href="./references#CD011289-bbs2-0011" title="NCT02441712 . Rehabilitation with patterned electrical neuromuscular stimulation for patients with patellofemoral pain (PENS for PFP). clinicaltrials.gov/ct2/show/NCT02441712 (first received 12 May 2015). ">NCT02441712</a>). There are no trials awaiting classification. A flow diagram summarising the study selection process is shown in <a href="#CD011289-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011289-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011289-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011289-sec-0064"> <h4 class="title">Included studies</h4> <p>We have provided full details on the individual studies in the <a href="./references#CD011289-sec-0132" title="">Characteristics of included studies</a> table. We contacted the authors of all studies for clarification and additional information and received responses from authors of five studies (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). One study, <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, was reported in two different articles, one of which reported the findings for the 15 female participants of the 22 participants in the full report. </p> <section id="CD011289-sec-0065"> <h5 class="title">Design</h5> <p>All eight included studies were randomised, controlled, parallel‐group clinical trials. Two of them were pilot studies (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>). <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> was a sports laboratory‐based study that assessed the immediate effects of a single session of NMES. <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> had three treatment groups; we considered the two groups testing different types of exercise (isokinetic versus isometric) together in this review. <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> had three treatment groups, of which one was excluded as it was not relevant for this review, and <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> had four groups, two of which were excluded as they were not relevant. </p> </section> <section id="CD011289-sec-0066"> <h5 class="title">Sample size</h5> <p>Overall, 390 participants were randomised and 345 were available for analysis. Sample sizes in the eight studies ranged from 16, in <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>, to 120, in <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>. The number of participants in the intervention group ranged from 7, in <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>, to 37, in <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>. </p> </section> <section id="CD011289-sec-0067"> <h5 class="title">Setting</h5> <p>The trials were conducted in five different countries: one in Switzerland (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>), two in the United Kingdom (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>), one in Austria (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>), three in Turkey (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>), and one in the United States (<a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>). The publication dates ranged from 1992, in <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>, to 2016, in <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>. </p> </section> <section id="CD011289-sec-0068"> <h5 class="title">Participants</h5> <p>All studies included participants with PFP diagnosed through clinical examination of the knee, including pain provoking clinical tests (prolonged sitting, kneeling, squatting, ascending or descending stairs), in <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>, <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>, <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>, and <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, and positive patellar compression tests (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>). Two studies also used magnetic resonance imaging for diagnosis (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>). Three trials included X‐rays to investigate anatomical bone changes (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). Four studies included only participants with unilateral complaints (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> and <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> included people with bilateral PFP, but the authors treated only the most symptomatic knee in these participants; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> included only people with bilateral PFP, and both knees were treated and evaluated; and <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> provided no information on the side(s) affected. Seven studies reported the minimum duration of symptoms (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>), which ranged from one month, in <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>, to six months (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>). The mean age of participants ranged from 25.4 years, in <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>, to 42.7 years, in <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>. <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> did not report the gender of the participants. All of the other seven trials recruited a higher percentage of females, ranging from 53% in <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> to 100% in <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>, which recruited females only. None of the included studies described the level of activity of their participants. </p> </section> <section id="CD011289-sec-0069"> <h5 class="title">Interventions and controls</h5> <p>All studies gave the participants in the intervention group an NMES portable device for use at home (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>), during an outpatient rehabilitation programme (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>), or in a research laboratory (<a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>). The participants using the portable device at home received instructions about the stimulation programme and electrode placement. In four studies, self adhesive electrodes were to be placed on the quadriceps muscles (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>). In two studies (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>), the investigators aimed to specifically stimulate the vastus medialis oblique (VMO) muscle. In one study (<a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>), the electrodes were positioned over the VMO and gluteus medius muscles (agonist muscles), and over the adductor and the hamstrings muscle groups (antagonist muscles). <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> did not describe the position of the electrodes. </p> <p><a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> used a novel form of NMES (patterned electrical neuromuscular stimulation (PENS) with a frequency of 50 Hz) that mimics voluntary movement patterns of muscular contractions (stimulation of the agonist muscles, followed by antagonist muscles), and compared it with a sham intervention ("sub sensory" treatment). </p> <p>Four studies compared NMES plus another intervention versus no NMES plus the same other intervention (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). The other intervention was an exercise programme in <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> and <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; an exercise programme and patellar taping in <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; and ice, patellar taping, and exercises in <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>. <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> and <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> used a high‐voltage pulsed galvanic stimulation (HVPGS) with a frequency of 60 Hz, and <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> and <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> used an NMES device with a frequency of 40 Hz and 30 Hz, respectively. </p> <p><a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> compared NMES (with sequentially combined periods of high and low frequencies (50 Hz and 10 Hz)) alone versus an exercise programme (isokinetic and isometric exercises). </p> <p>The last two studies compared different NMES programmes (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>). <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a> used an NMES device that simultaneously combined high and low frequencies superimposed, comparing it with an NMES device that sequentially combined high and low frequencies (control group). <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a> used a new type of NMES with simultaneous delivery of mixed frequencies, comparing it with a fixed‐frequency NMES device (control group). </p> <p>All studies reported that the intensity of stimulation was adjusted to the highest possible level that was tolerated by the participants. The duration of the stimulation session ranged from 10 minutes, in <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> and <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>, to four hours per day (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). NMES session frequency ranged from a single session, in <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, to seven times per week, in <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>. The treatment duration ranged from 15 minutes, in <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, to 12 weeks, in <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>. </p> </section> <section id="CD011289-sec-0070"> <h5 class="title">Outcomes</h5> <p>All studies evaluated outcomes in the short term, which was timed after the single session in <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, and at end of the treatment programme (3 weeks in <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> to 12 weeks in <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>). <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> also assessed participants at 12 months after the end of treatment (long term). Seven trials used a visual analogue scale (VAS) to assess knee pain (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). Three studies used the Kujala Patellofemoral Score to assess knee function (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>); one used the Cincinnati Knee Rating System (<a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>); one used the Lower Extremity Functional Scale (LEFS) (<a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>); and one used the Arpège function scale (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). Only two studies evaluated adverse events, such as muscle fatigue using bipolar electrode surface electromyography (EMG) (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>). Four studies assessed muscle flexion strength: <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a> and <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a> used an isokinetic dynamometer; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> used a specifically designed chair with a circuit configuration that measured maximal isometric contractions; and <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> used Lovett’s manual muscle test (grades from 0 to 5; higher indicates better muscle strength). Two studies assessed lower limb muscle function (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>), measured through performance tests such as step up and down and squat flexion. None of the included studies reported quality of life or participant satisfaction. </p> </section> </section> <section id="CD011289-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded two potentially eligible studies for reasons detailed in the <a href="./references#CD011289-sec-0133" title="">Characteristics of excluded studies</a> table (<a href="./references#CD011289-bbs2-0009" title="DursunN , DursunE , KiliçZ . Electromyographic biofeedback–controlled exercise versus conservative care for patellofemoral pain syndrome. Archives of Physical Medicine and Rehabilitation2001;82:1692‐5. ">Dursun 2001</a>; <a href="./references#CD011289-bbs2-0010" title="KuruT , YalimanA , DereliEE . Comparison of efficiency of Kinesio taping and electrical stimulation in patients with patellofemoral pain syndrome. Acta Orthopaedica et Traumatologica Turcica2012;46(5):385‐92. ">Kuru 2012</a>). Briefly, <a href="./references#CD011289-bbs2-0009" title="DursunN , DursunE , KiliçZ . Electromyographic biofeedback–controlled exercise versus conservative care for patellofemoral pain syndrome. Archives of Physical Medicine and Rehabilitation2001;82:1692‐5. ">Dursun 2001</a> investigated the effects of electromyographic biofeedback (EMG) on PFP, and <a href="./references#CD011289-bbs2-0010" title="KuruT , YalimanA , DereliEE . Comparison of efficiency of Kinesio taping and electrical stimulation in patients with patellofemoral pain syndrome. Acta Orthopaedica et Traumatologica Turcica2012;46(5):385‐92. ">Kuru 2012</a> was not a randomised controlled trial. </p> <section id="CD011289-sec-0072"> <h5 class="title">Ongoing studies</h5> <p>We found one ongoing study, which aimed to recruit 32 participants to test the results at four weeks of the same comparison as in <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>. Further details are given in <a href="./references#CD011289-sec-0134" title="">Characteristics of ongoing studies</a>. </p> </section> </section> </section> <section id="CD011289-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed studies for risk of bias ('low', 'high', or 'unclear') relating to seven domains. The results for individual studies are summarised in <a href="#CD011289-fig-0002">Figure 2</a>, with details given in the <a href="./references#CD011289-sec-0132" title="">Characteristics of included studies</a> table. An overall summary of the ratings for each domain is shown in <a href="#CD011289-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011289-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011289-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD011289-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011289-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD011289-sec-0074"> <h4 class="title">Allocation</h4> <p>Random sequence allocation was adequate in four studies: two studies used a computer‐generated randomisation list (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>); one used a sample of shuffled sealed envelopes, and the participant took one out of the batch (<a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>, in reply to our email); and one study used the coin‐tossing technique (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>, in reply to our email). The other four trials provided insufficient information about the randomisation process and were therefore judged as at unclear risk of bias for this domain (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). We judged all eight studies as at unclear risk of bias relating to allocation concealment. Six studies provided no details about the method used for allocation concealment (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> and <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> used sealed envelopes but did not mention if they were opaque. </p> </section> <section id="CD011289-sec-0075"> <h4 class="title">Blinding</h4> <p>Seven studies provided no information on participant blinding and were classified as being at high or unclear risk of performance bias depending on whether blinding would have been feasible: we judged five studies that compared different interventions between groups as at high risk of bias (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>), and two studies that compared the same intervention (different NMES parameters) as at unclear risk of bias for this domain (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>). <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> compared NMES with a sham control but, since the authors did not exclude people who had received previous NMES therapy, it is difficult to judge whether the blinding was effective; we therefore also classified this study as at unclear risk of bias for this domain. Regarding detection bias, four trials reported blinding of outcome assessors and were judged to be at low risk of bias (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>). <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> reported by email that no measures were used to ensure blinding of the outcome assessors, and was therefore judged as at high risk of bias. <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>, <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, and <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> did not clearly report if the outcome assessors were blinded; we judged the first two studies as being at unclear risk of bias for this domain, and <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> as at high risk of bias given the clear differences in the interventions. </p> </section> <section id="CD011289-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>We categorised only two studies as at low risk of bias for this domain because all participants completed the study (<a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>). <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> provided insufficient information to make a judgement regarding losses and was assessed as being at unclear risk of bias for this domain. We judged the remaining five trials as at high risk of bias because they had at least one of the following issues: a high dropout rate (&gt; 20%), an imbalance between groups due to loss of participants, no reporting of intention‐to‐treat analysis and uncertainty of the effects of postrandomisation exclusions due to adverse events (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). </p> </section> <section id="CD011289-sec-0077"> <h4 class="title">Selective reporting</h4> <p>None of the trials had a published study protocol or trial registration. It was unclear in six studies if the results included all expected outcomes (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>; <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>; <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>); furthermore, these studies did not consider adverse event as an outcome, and were therefore judged as at unclear risk of bias for this domain. We assessed two studies as at further high risk of bias: <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> because of the very short follow‐up and data inconsistencies between the two reports of the trial, and <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> because of contradictions between the text and tables for pain results. We categorised <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a> and <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a> as being at low risk of bias because although they considered only one adverse event (muscle fatigue), this is one of the most important adverse events in clinical practice. </p> </section> <section id="CD011289-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>Three studies were apparently free of other sources of bias (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>), including major between‐group imbalances in key baseline characteristics, and were rated as at low risk of bias for this domain. We judged four studies as at unclear risk of bias: <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> because of some imbalances in participant characteristics, particularly in pre‐training muscle strength; <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a> due to lack of information on participant characteristics at baseline; <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> because of some doubts as to the reliability of the presented data; and <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> because the authors did not provide information on the side(s) affected, and it was unclear which knee was treated. We judged <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> as at high risk of other bias due to there being a major difference between the two groups in the initial pain during activities data, given that pain is the top primary outcome of this review. </p> </section> </section> <section id="CD011289-sec-0079"> <h3 class="title" id="CD011289-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD011289-tbl-0001"><b>Summary of findings for the main comparison</b> Neuromuscular electrical stimulation + other intervention (e.g. exercise) versus same other intervention only for patellofemoral pain syndrome</a>; <a href="./full#CD011289-tbl-0002"><b>Summary of findings 2</b> Neuromuscular electrical stimulation versus exercise for patellofemoral pain syndrome</a> </p> <section id="CD011289-sec-0080"> <h4 class="title">Comparison 1: NMES versus placebo</h4> <p>One laboratory study compared NMES versus sham NMES in a single 15‐minute session (<a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>). <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> assessed knee pain immediately at the end of the treatment in 22 participants. This study did not report on all other outcomes pertinent to our review, such as function or adverse events. We rated the quality of the evidence as very low, downgrading one level for serious risk of bias, one level for indirectness (the single session of NMES does not correspond to that used in clinical practice; the results immediately post‐treatment may not be representative), and one level for serious imprecision, reflecting the low numbers available. </p> <section id="CD011289-sec-0081"> <h5 class="title">Knee pain (VAS: 0 to 10; higher scores = worse pain)</h5> <p><a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a> found NMES was associated with reduced pain during a single leg squat (mean difference (MD) ‐1.90, 95% confidence interval (CI) ‐3.10 to ‐0.70) and during a lateral step‐down (MD ‐2.20, 95% CI ‐3.47 to ‐0.93) (<a href="./references#CD011289-fig-0004" title="">Analysis 1.1</a>). However, the 95% CI also included the probability that this benefit may not be clinically relevant because the 95% CI overlap the minimal clinically important difference (MCID) for VAS during activities (1.3 out of 10 points; <a href="./references#CD011289-bbs2-0019" title="CrossleyKM , BennellKL , CowanSM , GreenS . Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid?. Archives of Physical Medicine and Rehabilitation2004;85(5):815‐22. ">Crossley 2004</a>). </p> </section> </section> <section id="CD011289-sec-0082"> <h4 class="title">Comparison 2: NMES plus other active intervention (e.g. exercise) versus no NMES plus same other active intervention </h4> <p>Four studies compared NMES versus no NMES, where all participants received another intervention, typically exercise. Two studies compared NMES associated with exercise versus exercise alone (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>). In <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>, the common co‐intervention was an exercise programme and patellar taping, and in <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>, all participants received exercises, patellar taping, and ice. All studies reported results at the end of the treatment (short term): three weeks in <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>, six weeks in <a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> and <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a>, and 12 weeks in <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>. <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> also reported results at one year after treatment (long term). None of the four trials reported on adverse events, performance tests, quality of life or participant satisfaction. We rated the quality of the evidence for all reported outcomes as very low, downgrading one or two levels for serious or very serious risk of bias, and one or two levels for serious or very serious imprecision, reflecting the low numbers available and often broad confidence intervals. </p> <section id="CD011289-sec-0083"> <h5 class="title">Knee pain (VAS: 0 to 10; higher scores = worse pain)</h5> <p>Pooled results from three studies showed NMES was associated with lower pain scores in the short term (ranging from 3 to 12 weeks): MD ‐1.63, 95% CI ‐2.23 to ‐1.02; 118 participants; 3 studies; I<sup>2</sup> = 2%; <a href="./references#CD011289-fig-0005" title="">Analysis 2.1</a> (<a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a>; <a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a>; <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). However, this benefit may not be clinically relevant since the absolute value (1.02) for the upper 95% CI was less than the MCID for VAS during activities (1.5 to 2.0, out of 10 points; <a href="./references#CD011289-bbs2-0019" title="CrossleyKM , BennellKL , CowanSM , GreenS . Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid?. Archives of Physical Medicine and Rehabilitation2004;85(5):815‐22. ">Crossley 2004</a>). </p> <p>Conversely, <a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> (30 participants), which evaluated knee pain during three activities after six weeks of treatment, reported clinically important higher pain scores in the NMES group during step‐down (MD 3.32, 95% CI 2.38 to 4.26), and step‐up (MD 3.15, 95% CI 2.10 to 4.20); <a href="./references#CD011289-fig-0006" title="">Analysis 2.2</a>. This did not apply for pain during squatting (MD 0.58, 95% CI ‐0.91 to 2.07). However, these results must be considered in the context of the imbalances in baseline pain scores, which were statistically significantly higher in the NMES group: step‐down: MD 2.12, 95% CI 0.2 to 4.04; step‐up: MD 1.90, 95% CI 0.01 to 3.79; and during squat: MD 1.77, 95% CI 0.22 to 3.32. Additionally, these findings disfavouring NMES were contradicted in the abstract conclusions for this trial, which stated that "Additional HVPGS [NMES] application in PFP rehabilitation may decrease pain levels during activities including step up and down". </p> <p><a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> reported that the NMES group had a median pain score of 1.5 (interquartile range (IQR) 0.3 to 2.8; 18 participants) at 12 weeks, while the control group had a median score of 1.3 (IQR 0.4 to 3.3; 18 participants) (reported P = 0.64). At one‐year follow‐up, the NMES group had a higher median score of 1.8 (IQR 0.1 to 3.6; 16 participants), while the control group had a median score of 0.4 (IQR 0.2 to 3.4; 13 participants) (P value not available). However, the study reported that the change score for pain at one‐year follow‐up "remained constant" to that at 12 weeks (<a href="./references#CD011289-fig-0005" title="">Analysis 2.1</a>). </p> </section> <section id="CD011289-sec-0084"> <h5 class="title">Knee function</h5> <p><a href="./references#CD011289-bbs2-0007" title="KayaD , YükselÝ , CallaghanMJ , GüneyH , AtayÖA , ÇitakerS , et al. High voltage pulsed galvanic stimulation adjunct to rehabilitation program for patellofemoral pain syndrome: a prospective randomized controlled trial. Fizyoterapi Rehabilitasyon2013;24(1):1‐8. ">Kaya 2013</a> measured knee function using the Lower Extremity Functional Scale (LEFS) scale (0 to 80; higher scores indicate better function) after six weeks of treatment. <a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a> assessed knee function using the Cincinnati Knee Rating System (6 to 100; higher scores indicating better function) after three weeks of treatment. Pooled results from these two studies did not confirm a difference between the groups (standardised mean difference 0.37 favouring NMES, 95% CI ‐0.11 to 0.84; 70 participants; I<sup>2</sup> = 7%; <a href="./references#CD011289-fig-0007" title="">Analysis 2.3</a>). The between‐group differences in the two scores in the individual trials were also small and unlikely to be clinically important (LEFS scale: MD 0.73; Cincinnati score: MD 4.65). </p> <p><a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> evaluated knee function using the Kujala Patellofemoral Score (KPS) (0 to 100; higher scores indicating better function) and found no statistically significant difference between groups after the end of the 12‐week treatment and at one year. After 12 weeks, the NMES group had a median score of 89 (IQR 82 to 96; 18 participants), while the control group had a median score of 90 (IQR 85 to 95; 18 participants) (reported P = 0.29). At one‐year follow‐up, the NMES group had a median of 94 (IQR 88 to 96; 16 participants), while the control group had a median of 95 (IQR 85 to 96; 13 participants) (P value not available). There was no clinically important difference in change score for KPS at 12 weeks (MD 3.70, 95% CI ‐2.90 to 10.30; 36 participants; <a href="./references#CD011289-fig-0008" title="">Analysis 2.4</a>). The study reported that the change score for KPS at one‐year follow‐up remained constant. </p> </section> <section id="CD011289-sec-0085"> <h5 class="title">Muscle strength</h5> <p><a href="./references#CD011289-bbs2-0001" title="AkarcaliI . Additional information on random sequence generation, allocation concealment and blinding [personal communication] Email to: AL Martimbianco 10 March 2015. AkarcaliI , TugayN , KayaD , AtayA , DoralMN . The role of high voltage electrical stimulation in the rehabilitation of patellofemoral pain. The Pain Clinic2002;14(3):207–12. ">Akarcali 2002</a> assessed muscle strength using Lovett’s manual muscle test (graded between 0 and 5; higher scores indicating better muscle strength). There was very little difference between the two groups with good or normal muscle strength (grades 4 and 5) at the end of the six‐week treatment: 20/20 versus 21/22; risk ratio 1.04, 95% CI 0.92 to 1.19; very low‐quality evidence; <a href="./references#CD011289-fig-0009" title="">Analysis 2.5</a>. </p> <p><a href="./references#CD011289-bbs2-0002" title="BilyW . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 16 March 2015. BilyW . Additional information regarding which knee was treated and assessed [personal communication]. Email to: AL Martimbianco 9 August 2016. BilyW , TrimmelL , MödlinM , KaiderA , KernH . Training program and additional electric muscle stimulation for patellofemoral pain syndrome: a pilot study. Archives of Physical Medicine and Rehabilitation2008;89:1230‐6. ">Bily 2008</a> (36 participants) evaluated isometric knee extensor strength (measured in newtons (N)) through a specifically designed chair (see <a href="./references#CD011289-sec-0132" title="">Characteristics of included studies</a>). Neuromuscular electrical stimulation was associated with greater muscle strength at 12 weeks (30° knee flexion: MD 38.30 N, 95% CI 13.71 to 62.89; and 60° knee flexion: MD 50.00 N, 95% CI 11.30 to 88.70; <a href="./references#CD011289-fig-0010" title="">Analysis 2.6</a>). However, we are not confident about the clinical relevance of these differences, especially since the muscle strengths before training were greater in the NMES group at both knee flexion settings (MD 14 N and 36 N). </p> </section> </section> <section id="CD011289-sec-0086"> <h4 class="title">Comparison 3: NMES versus exercise</h4> <p>One trial compared NMES versus exercises (isometric and isokinetic exercises), reporting results at the end of the four‐week treatment (short term) for 94 participants (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). In our analyses, we pooled data from the two exercise groups. Since <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> did not report which knee was treated and assessed, we considered the participant as the unit of analysis. <a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> did not report on knee pain, adverse events, performance tests, quality of life or participant satisfaction. For both reported outcomes, we rated the quality of the evidence as very low, downgrading one level for serious risk of bias, one level for indirectness given the protracted application of NMES (four hours per day), and one level for serious imprecision, reflecting the low numbers available. </p> <section id="CD011289-sec-0087"> <h5 class="title">Knee function</h5> <p><a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>, which used the Arpège function scale (0 to 18; higher scores indicating better function) to assess knee function, found no important difference in knee function at four weeks between the two groups (MD ‐0.94, 95% CI ‐2.10 to 0.22; 94 participants; <a href="./references#CD011289-fig-0011" title="">Analysis 3.1</a>). </p> </section> <section id="CD011289-sec-0088"> <h5 class="title">Muscle strength</h5> <p><a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a> assessed muscle strength using an isokinetic dynamometer (measured in Nm) at speeds of 30°/s and 300°/s. There were no important differences in strength at four weeks between the two groups at either speed (at 30°/s: MD 0.06 Nm, 95% CI ‐29.67 to 29.79; 94 participants; at 300°/s: MD 1.04 Nm, 95% CI ‐14.00 to 16.08; 94 participants; <a href="./references#CD011289-fig-0012" title="">Analysis 3.2</a>). </p> </section> </section> <section id="CD011289-sec-0089"> <h4 class="title">Comparison 4: NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies) </h4> <p>Two studies assessed this comparison (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>). <a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a> compared simultaneously delivered high‐low frequencies versus sequentially delivered high‐low frequencies (control group). <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a> compared simultaneously delivered high‐low frequencies versus a fixed frequency (control group). Both studies assessed outcomes in the short term, at the end of the six‐week treatment programme. Neither study reported on quality of life or participant satisfaction. We rated the quality of the evidence as very low for all reported outcomes, downgrading one level for serious risk of bias, one level for indirectness given the experimental nature of the intervention, and one level for serious imprecision, reflecting the low numbers available. </p> <section id="CD011289-sec-0090"> <h5 class="title">Knee pain (VAS: 0 to 10; higher scores = worse pain)</h5> <p>Both studies assessed this outcome and provided very low‐quality evidence of no important difference in knee pain between the two groups at six weeks (MD 0.40, 95% CI ‐1.76 to 2.56; 14 participants; 1 study; <a href="./references#CD011289-fig-0013" title="">Analysis 4.1</a>). In <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a> (74 participants), participants in the NMES group with simultaneous frequencies had a median score of 2 points (IQR 0 to 4; 37 participants), and those in the NMES group with fixed frequencies had a median score of 2 points (IQR 1 to 4; 37 participants) (reported P = 0.249). </p> </section> <section id="CD011289-sec-0091"> <h5 class="title">Knee function (KPS: 0 to 100; higher scores = better function)</h5> <p>We found very low‐quality evidence of no important difference between the groups in knee function at six weeks (MD ‐1.16, 95% CI ‐6.79 to 4.47; 88 participants; 2 studies; I<sup>2</sup> = 15%; <a href="./references#CD011289-fig-0014" title="">Analysis 4.2</a>). </p> </section> <section id="CD011289-sec-0092"> <h5 class="title">Adverse events</h5> <p>Both studies assessed muscle fatigue only as an adverse event (quadriceps fatigue rates through bipolar electrode surface EMG, at 60% of maximum contraction for 60 seconds). Both studies reported no statistically significant difference between groups (<a href="./references#CD011289-bbs2-0003" title="CallaghanMJ . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA , WinstanleyJ . A comparison of two types of electrical stimulation of the quadriceps in the treatment of patellofemoral pain syndrome. A pilot study. Clinical Rehabilitation2001;15:637–46. ">Callaghan 2001</a>: reported P &gt; 0.05; <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>: reported P = 0.724). There were no reports of dropouts due to adverse events. </p> </section> <section id="CD011289-sec-0093"> <h5 class="title">Functional performance tests</h5> <p>Both studies assessed this outcome by combining the step‐up and step‐down tests in a single measure ('steps up and down') and presented the total number of steps achieved until the onset of patellar pain. Neither study found evidence showing a difference between the two groups at six weeks (MD 4.50 steps, 95% CI ‐8.21 to 17.21; 14 participants; 1 study; <a href="./references#CD011289-fig-0015" title="">Analysis 4.3</a>). In <a href="./references#CD011289-bbs2-0004" title="CallaghanM . Additional information on NMES parameters [personal communication]. Email to: AL Martimbianco 9 March 2015. CallaghanMJ , OldhamJA . Electric muscle stimulation of the quadriceps in the treatment of patellofemoral pain. Archives of Physical Medicine and Rehabilitation2004;85:956‐62. ">Callaghan 2004</a>, the participants of the NMES group with simultaneous frequencies had a median of 27 steps (IQR 16 to 46; 37 participants), and those in the NMES fixed‐frequency group had a median of 28 steps (IQR 11 to 60; 37 participants) (reported P = 0.562). </p> </section> <section id="CD011289-sec-0094"> <h5 class="title">Muscle strength</h5> <p>Both studies assessed quadriceps isometric and isokinetic muscle strength using an isokinetic dynamometer (measured in Nm), with angular velocity at 90°/s. Pooled results showed no evidence of important differences between the two groups at six weeks for either isometric muscle strength (MD ‐1.15 Nm, 95% CI ‐16.24 to 13.94; 88 participants; 2 studies; I<sup>2</sup> = 0%; <a href="./references#CD011289-fig-0016" title="">Analysis 4.4</a>) or isokinetic muscle strength (MD ‐7.28 Nm, 95% CI ‐24.45 to 9.89; 88 participants; 2 studies; I<sup>2</sup> = 0%; <a href="./references#CD011289-fig-0017" title="">Analysis 4.5</a>). </p> </section> </section> <section id="CD011289-sec-0095"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>There were insufficient data to perform our planned subgroup and sensitivity analyses.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011289-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011289-sec-0096">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011289-sec-0150">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011289-sec-0096"></div> <section id="CD011289-sec-0097"> <h3 class="title" id="CD011289-sec-0097">Summary of main results</h3> <p>This review evaluated the effects (benefits and harms) of NMES for people with a diagnosis of PFP. We included eight heterogeneous randomised clinical trials reporting results for a total of 345 participants. These studies contributed data to one of the four comparisons summarised below. </p> <section id="CD011289-sec-0098"> <h4 class="title">NMES alone versus placebo (sham NMES)</h4> <p>One laboratory‐based study compared a single 15‐minute session of NMES versus sham (placebo control) in 22 participants. This study reported only on pain during two functional activities assessed immediately after treatment (short term). We found very low‐quality evidence (downgraded one level for serious risk of bias, one level for indirectness given that the single 15‐minute session of NMES does not correspond to clinical practice, and one level for imprecision) that NMES is associated with reduced pain during both functional activities. However, the 95% CI results also include the probability that the difference was not clinically important. There were no data on function, adverse events, or longer‐term outcomes. Overall, the evidence from this study is limited and of uncertain clinical relevance. </p> </section> <section id="CD011289-sec-0099"> <h4 class="title">NMES plus another intervention (e.g. exercise) versus no NMES control plus the same other intervention </h4> <p>The evidence for this comparison, which is summarised in <a href="./full#CD011289-tbl-0001">summary of findings Table for the main comparison</a>, was from four trials, each testing a different multiple‐session NMES programme. Exercise was the common intervention in all four trials in this comparison; in one trial patellar taping was also used, and in another trial patellar taping and ice were also used. </p> <p>We found very low‐quality evidence from three trials (118 participants) that NMES is associated with reduced pain in the short term (at the end of the 3 and 12 weeks' treatment programmes). However, the 95% CI included the possibility that the difference is not clinically important. We found very low‐quality evidence from pooled data from two trials of little effect of NMES on knee function at the end of treatment (three and six weeks). There was inconclusive and very low‐quality evidence from one trial (29 participants) of little effect of NMES on pain and function at one‐year follow‐up. None of the four trials reported on adverse effects of treatment. </p> </section> <section id="CD011289-sec-0100"> <h4 class="title">NMES versus exercise</h4> <p>The evidence for this comparison, which is summarised in <a href="./full#CD011289-tbl-0002">summary of findings Table 2</a>, was from one trial (94 participants) that compared NMES applied four hours per day on a daily basis for four weeks, with two types of exercises (isometric and isokinetic). The trial did not report on knee pain or adverse events. There was very low‐quality evidence of no important difference between the two groups in knee function at the end of the four‐week treatment (short term). </p> </section> <section id="CD011289-sec-0101"> <h4 class="title">Different types of NMES</h4> <p>Two studies reporting data for 88 participants compared simultaneously delivered high‐low frequencies NMES versus control NMES, which was either sequentially delivered high‐low frequencies (14 participants) or fixed frequency (74 participants). We found very low‐quality evidence of no important differences at the end of the six‐week treatment programme between the simultaneous frequencies NMES and the control NMES in overall knee pain, knee function, or quadriceps fatigue (adverse event). </p> </section> </section> <section id="CD011289-sec-0102"> <h3 class="title" id="CD011289-sec-0102">Overall completeness and applicability of evidence</h3> <p>Overall, outcome data from the eight included trials were available for 345 participants, thus 88.5% of the 390 randomised participants. The majority (26 participants; 22% of 120) were lost from the largest and oldest trial (<a href="./references#CD011289-bbs2-0006" title="GobeletC , FreyM , BonardA . Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatismeet des Maladies Osteo‐Articulaires1992;59(1):23‐7. ">Gobelet 1992</a>). The eight trials contributed data to one of four comparisons, thus reducing again the quantity of data available to address individual questions. Clinical and methodological heterogeneity among studies in the same comparison precluded the pooling of data for several outcomes. The maximum number of participants in any analysis was 118 participants from three studies (<a href="./references#CD011289-fig-0005" title="">Analysis 2.1</a>). There were very few data for longer‐term outcomes. </p> <p>Except <a href="./references#CD011289-bbs2-0005" title="GlavianoN . Additional information on random sequence generation, allocation concealment and blinding (participants, personnel and assessors) [personal communication]. Email to: AL Martimbianco 12 August 2016. GlavianoNR , HuntsmanS , DembeckA , HartJM , SalibaS . Improvements in kinematics, muscle activity and pain during functional tasks in females with patellofemoral pain following a single patterned electrical stimulation treatment. Clinical Biomechanics2016;32:20‐7. GlavianoNR , SalibaSA . Immediate effect of patterned neuromuscular electrical stimulation on pain and muscle activation in individuals with patellofemoral pain. Journal of Athletic Training2016;51(2):118‐28. ">Glaviano 2016</a>, which was carried out in a sports laboratory, the trials were conducted in typical settings, with NMES applied in outpatients or at home. </p> <p>Where details were provided, the study populations were representative of those treated for PFP. In three studies, the minimum duration of the complaints was from one to three months, which could present a better prognosis than the other four studies, which only included participants who had symptoms for more than six months. Three studies stipulated a maximum duration of symptoms of three and five years, and a further study recorded a maximum duration of symptoms of five years (<a href="./references#CD011289-bbs2-0008" title="TunayVB . Additional information on NMES parameters and exercise programme [personal communication]. Email to: AL Martimbianco 12 March 2015. TunayVB , BaltaciG , TunayS , ErgunN . A comparison of different treatment approaches to patellofemoral pain syndrome. The Pain Clinic2003;15(2):179‐84. ">Tunay 2003</a>). On duration of symptoms alone, there was clearly a large variation within each study. None of the included studies reported the level of physical activity of their participants, which can also influence treatment effect. Finally, it was not possible to assess the influence of age and gender in the effectiveness of the intervention, but these factors were in accordance with the incidence of the disease. The variation in the inclusion and diagnostic criteria and the actual population characteristics could thus limit the applicability of the evidence. </p> <p>The included studies used different NMES devices and stimulation parameters (e.g. frequency, pulse waveform, pulse duration, duty cycle, intensity, and treatment duration), as well as different types of co‐interventions (exercises, taping, ice). Only one study compared NMES with placebo, and although this comparison is considered clinically relevant (since it evaluates the specific active effect of electrostimulation), this study evaluated only a single NMES session, which could be insufficient to produce a true clinical benefit. In contrast, in the study that compared NMES versus exercise, participants were prescribed NMES for four hours a day, which seems to be very demanding and impracticable. Moreover, the length of treatment also varied between studies, ranging from a single session to 12 weeks. </p> <p>Although appropriate outcome measures were generally used, most studies did not record or report on adverse events, and none reported on quality of life and participant satisfaction, both of which are important patient‐related outcomes. Moreover, most studies measured the outcome immediately at the end of treatment (in the short term), and there were very few data on the longer‐term effects of NMES. </p> <p>All these factors contribute to the poor quality and applicability of the available evidence. For example, it is not possible to identify the best NMES programme and whether it is applicable to all people with PFP. </p> </section> <section id="CD011289-sec-0103"> <h3 class="title" id="CD011289-sec-0103">Quality of the evidence</h3> <p>All eight trials included in this review were at high risk of bias for at least one of the seven assessed domains, and at unclear risk of bias for several other domains, notably for allocation concealment, where no trial was judged as meeting the criteria for low risk of selection bias. We considered the overall quality of the evidence, based on the GRADE approach, as very low for all primary outcomes for each comparison, which means that we are very uncertain about the estimates of treatment effect. We downgraded evidence levels due methodological limitations that resulted in serious risk of bias, imprecision (small sample size and usually wide confidence intervals), and indirectness (the NMES scheme did not correspond to what is used in clinical practice, and the time point of pain assessment was very far from the end of the intervention). We did not assess publication bias due to the small number of studies available for pooling. While there was clinical heterogeneity as illustrated above, statistical heterogeneity was low in all pooled analyses, and thus we did not downgrade for inconsistency. </p> </section> <section id="CD011289-sec-0104"> <h3 class="title" id="CD011289-sec-0104">Potential biases in the review process</h3> <p>To minimise the probability of bias, we followed the recommendations on searching, trial selection, data extraction and analysis in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011289-bbs2-0025" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). The search strategy was broad and sensitive, and we anticipate that we have identified all fully published randomised clinical trials that met the inclusion criteria. However, we cannot rule out that we have missed some trials, especially unpublished trials that are available, for example, only in conference proceedings. We contacted all trial authors via email for additional information. Although adhering to our protocol, our decision to pool data from clearly heterogeneous trials may be questioned (comparison 2). However, we have been cautious in our interpretation of the results and made clear the limitations in the applicability of the evidence. </p> </section> <section id="CD011289-sec-0105"> <h3 class="title" id="CD011289-sec-0105">Agreements and disagreements with other studies or reviews</h3> <p>Although we did not find another published systematic review on this topic, we located two Cochrane Reviews on related topics. One Cochrane Review assessed the effects of NMES for quadriceps strengthening before and after total knee replacement (<a href="./references#CD011289-bbs2-0036" title="MonaghanB , CaulfieldB , O’MathúnaDP . Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007177.pub2] ">Monaghan 2010</a>). Based on two studies with a high risk of bias, <a href="./references#CD011289-bbs2-0036" title="MonaghanB , CaulfieldB , O’MathúnaDP . Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007177.pub2] ">Monaghan 2010</a> concluded that the evidence for the use of NMES for this clinical situation was unclear. A more recent Cochrane Review that included 31 heterogeneous trials evaluated exercises for treating PFP (<a href="./references#CD011289-bbs2-0051" title="van derHeijdenRA , LankhorstNE , vanLinschotenR , Bierma‐ZeinstraSMA , vanMiddelkoopM . Exercise for treating patellofemoral pain syndrome. Cochrane Database of Systematic Reviews2015, Issue 1. [DOI: 10.1002/14651858.CD010387.pub2] ">van der Heijden 2015</a>). <a href="./references#CD011289-bbs2-0051" title="van derHeijdenRA , LankhorstNE , vanLinschotenR , Bierma‐ZeinstraSMA , vanMiddelkoopM . Exercise for treating patellofemoral pain syndrome. Cochrane Database of Systematic Reviews2015, Issue 1. [DOI: 10.1002/14651858.CD010387.pub2] ">van der Heijden 2015</a> concluded that there is very low‐quality but consistent evidence that exercise may improve clinical outcomes such as pain, function, and long‐term recovery. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011289-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011289-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011289-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011289-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NMES versus placebo (sham device), Outcome 1 Knee pain during activities (end of the treatment, single 15‐minute NMES session): VAS scale: 0 to 10; higher score = worse pain." data-id="CD011289-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 NMES versus placebo (sham device), Outcome 1 Knee pain during activities (end of the treatment, single 15‐minute NMES session): VAS scale: 0 to 10; higher score = worse pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 1 Knee pain (end of the treatment, 3 to 12 weeks): VAS scale: 0 to 10; higher score = worse pain." data-id="CD011289-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 1 Knee pain (end of the treatment, 3 to 12 weeks): VAS scale: 0 to 10; higher score = worse pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 2 Knee pain during activities (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain." data-id="CD011289-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 2 Knee pain during activities (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 3 Knee function (end of the treatment, 3 and 6 weeks): Cincinnati Knee Rating System and LEFS; higher score = better function." data-id="CD011289-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 3 Knee function (end of the treatment, 3 and 6 weeks): Cincinnati Knee Rating System and LEFS; higher score = better function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 4 Change score for KPS (end of treatment, 12 weeks) (0 to 100; higher score = better function)." data-id="CD011289-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 4 Change score for KPS (end of treatment, 12 weeks) (0 to 100; higher score = better function). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 5 Good or normal muscle strength (end of the treatment, 6 weeks): grades 4 to 5 Lovett’s manual muscle scale." data-id="CD011289-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 5 Good or normal muscle strength (end of the treatment, 6 weeks): grades 4 to 5 Lovett’s manual muscle scale. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 6 Muscle strength (end of the treatment, 12 weeks): isokinetic dynamometer (N)." data-id="CD011289-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 NMES (+ other intervention) versus no NMES (+ same other intervention), Outcome 6 Muscle strength (end of the treatment, 12 weeks): isokinetic dynamometer (N). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NMES versus exercise, Outcome 1 Knee function (end of the treatment, 4 weeks): Arpège function scale: 0 to 18; higher score = better function." data-id="CD011289-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 NMES versus exercise, Outcome 1 Knee function (end of the treatment, 4 weeks): Arpège function scale: 0 to 18; higher score = better function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 NMES versus exercise, Outcome 2 Muscle strength (end of the treatment, 4 weeks): isokinetic dynamometer (Nm)." data-id="CD011289-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 NMES versus exercise, Outcome 2 Muscle strength (end of the treatment, 4 weeks): isokinetic dynamometer (Nm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 1 Knee pain (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain." data-id="CD011289-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 1 Knee pain (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 2 Knee function (end of the treatment, 6 weeks): KPS: 0 to 100 scale; higher score = better function." data-id="CD011289-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 2 Knee function (end of the treatment, 6 weeks): KPS: 0 to 100 scale; higher score = better function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 3 Functional performance (end of the treatment, 6 weeks): number of steps up and down until pain." data-id="CD011289-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 3 Functional performance (end of the treatment, 6 weeks): number of steps up and down until pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 4 Quadriceps isometric muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm)." data-id="CD011289-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 4 Quadriceps isometric muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011289-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/urn:x-wiley:14651858:media:CD011289:CD011289-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_t/tCD011289-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 5 Quadriceps isokinetic muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm)." data-id="CD011289-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies), Outcome 5 Quadriceps isokinetic muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/media/CDSR/CD011289/image_n/nCD011289-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011289-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Neuromuscular electrical stimulation + other intervention (e.g. exercise) versus same other intervention only for patellofemoral pain syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Neuromuscular electrical stimulation (NMES) plus other intervention (e.g. exercise) versus no NMES plus same other intervention for patellofemoral pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with patellofemoral pain syndrome<sup>1</sup><br/> <b>Settings:</b> outpatient rehabilitation and home‐based therapy<br/> <b>Intervention:</b> NMES<sup>2</sup> plus other active intervention (e.g. exercise)<sup>3</sup> </p> <p><b>Comparison:</b> no NMES control plus same other active intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No NMES plus same other intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NMES plus other intervention (e.g. exercise)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (short term)<br/> VAS scale: 0 to 10; higher score = worse pain.<br/> Follow‐up: 3 to 12 weeks (all were at the end of the treatment programme<sup>2</sup>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee pain ranged across control groups from<br/> <b>2.36 to 2.70 points</b>. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee pain in the intervention groups was<br/> <b>1.63 lower</b><br/> (2.23 to 1.02 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.63 (‐2.23 to ‐1.02)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This difference may not be clinically important since the MCID for VAS (1.5 to 2.0, out of 10 points)<sup>5</sup> lies within the 95% CI. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (long term)<br/> VAS scale: 0 to 10; higher score = worse pain.<br/> Follow‐up: 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median pain score in the study control group was <b>0.4 points</b> (IQR 0.2 to 3.4). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median pain score in the NMES group was <b>1.8 points</b> (IQR 0.1 to 3.6). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was reported as not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (short term)<br/> 2 tools used: Cincinnati Knee Rating System (6 to 100; higher scores = better function) and Lower Extremity Functional Scale (LEFS) scale (0 to 80; higher scores = better function).<br/> Follow‐up: 3 to 6 weeks (at the end of the treatment programme) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the study control groups was<br/> <b>72.4</b> (LEFS scale) and <b>83.3</b> (Cincinnati score). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in knee function in the intervention groups was<br/> <b>0.37 SDs higher</b><br/> (0.11 lower to 0.84 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.37 (‐0.11 to 0.84)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> <p>However, the mean differences in the 2 trials were small and unlikely to be clinically important (LEFS scale: MD 0.73; Cincinnati score: MD 4.65). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (long term) </p> <p>Kujala Patellofemoral Score (KPS) (0 to 100; higher score = better function).<br/> Follow‐up: 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median KPS in the study control group was <b>95</b> (IQR 85 to 96). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median KPS in the NMES group was <b>94</b> (IQR 88 to 96). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The very small difference was reported as not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not measured </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>MCID:</b> minimal clinically important difference; <b>MD</b> : mean difference; <b>SD:</b> standard deviation; <b>SMD</b> : standardised mean difference; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Where reported, there was a higher percentage of females (63% to 100%). The mean ages of the participants in the four trials ranged from 25 to 39 years. There was a wide duration of symptoms, with the minimum duration of symptoms for trial inclusion ranging from one to six months.<br/> <sup>2</sup>The format of the NMES varied among the four trials. Sessions of NMES lasted between 10 to 20 minutes, applied 2 to 5 times a week, for between 3 and 12 weeks.<br/> <sup>3</sup>The co‐intervention in all four trials was exercise. Patellar taping was also applied to all participants in two trials, and ice was applied in one trial.<br/> <sup>4</sup>We downgraded the evidence two levels due to very serious risk of bias (performance bias), one level for imprecision reflecting small sample size, and one level for indirectness (time point of pain assessment was very far from the end of the intervention).<br/> <sup>5</sup>The minimal clinically important difference for visual analogue scale usual pain was set at 1.5 to 2.0 (out of 10) points (Crossley et al. Archives of Physical Medicine and Rehabilitation 2004;85(5):815‐22).<br/> <sup>6</sup>We downgraded the evidence two levels due to very serious risk of bias (performance, detection, and attrition biases) and two levels for imprecision reflecting single‐trial data and small sample size.<br/> <sup>7</sup>We downgraded the evidence two levels due to very serious risk of bias (performance bias) and one level for imprecision reflecting small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Neuromuscular electrical stimulation + other intervention (e.g. exercise) versus same other intervention only for patellofemoral pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011289-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Neuromuscular electrical stimulation versus exercise for patellofemoral pain syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Neuromuscular electrical stimulation (NMES) versus exercise for patellofemoral pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with patellofemoral pain syndrome<br/> <b>Settings:</b> at home<br/> <b>Intervention:</b> NMES (2‐hour session, twice a day, every day for 4 weeks)<sup>1</sup> </p> <p><b>Comparison:</b> exercise (either isokinetic or isometric; data combined in the analyses) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NMES </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (short term: &lt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee pain</b> (longer term: &gt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b><br/> (short term) <br/> Arpège function scale (0 to 18; higher score = better function).<br/> Follow‐up: 4 weeks (at end of treatment) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the study control group was<br/> <b>15.34 points</b>. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean knee function in the intervention groups was<br/> <b>0.94 lower</b><br/> (2.1 lower to 0.22 higher). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.94 (‐2.10 to 0.22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Knee function</b> (longer term: &gt; 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>MD</b>: mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>This very demanding schedule is unlikely to be found in clinical practice.<br/> <sup>2</sup>We downgraded the evidence two levels for very serious risk of bias (including high risk of performance bias and attrition bias), one level for imprecision (low numbers and wide 95% confidence interval), and one level for indirectness (the scheme used for NMES (during 4 hours/day) does not correspond to that used in clinical practice). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Neuromuscular electrical stimulation versus exercise for patellofemoral pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/full#CD011289-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011289-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NMES versus placebo (sham device)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Knee pain during activities (end of the treatment, single 15‐minute NMES session): VAS scale: 0 to 10; higher score = worse pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Pain during a single‐leg squat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Pain during a lateral step‐down</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NMES versus placebo (sham device)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011289-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NMES (+ other intervention) versus no NMES (+ same other intervention)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Knee pain (end of the treatment, 3 to 12 weeks): VAS scale: 0 to 10; higher score = worse pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.23, ‐1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Knee pain during activities (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Pain during step‐down</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Pain during step‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Pain during squat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Knee function (end of the treatment, 3 and 6 weeks): Cincinnati Knee Rating System and LEFS; higher score = better function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [‐0.11, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change score for KPS (end of treatment, 12 weeks) (0 to 100; higher score = better function) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Good or normal muscle strength (end of the treatment, 6 weeks): grades 4 to 5 Lovett’s manual muscle scale <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Muscle strength (end of the treatment, 12 weeks): isokinetic dynamometer (N) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Isometric strength with 30° knee flexion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Isometric strength with 60° knee flexion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NMES (+ other intervention) versus no NMES (+ same other intervention)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011289-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NMES versus exercise</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Knee function (end of the treatment, 4 weeks): Arpège function scale: 0 to 18; higher score = better function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Muscle strength (end of the treatment, 4 weeks): isokinetic dynamometer (Nm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Isokinetic dynamometer at 30°/s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Isokinetic dynamometer at 300°/s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NMES versus exercise</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011289-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Knee pain (end of the treatment, 6 weeks): VAS scale: 0 to 10; higher score = worse pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Simultaneous versus sequential delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Knee function (end of the treatment, 6 weeks): KPS: 0 to 100 scale; higher score = better function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.16 [‐6.79, 4.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Simultaneous versus sequential delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.90 [‐16.14, 4.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Simultaneous versus fixed delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐5.84, 7.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Functional performance (end of the treatment, 6 weeks): number of steps up and down until pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Simultaneous versus sequential delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Quadriceps isometric muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.15 [‐16.24, 13.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Simultaneous versus sequential delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.40 [‐25.83, 32.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Simultaneous versus fixed delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐20.42, 14.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Quadriceps isokinetic muscle strength (end of the treatment, 6 weeks): dynamometer at 90°/s (Nm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.28 [‐24.45, 9.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Simultaneous versus sequential delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.10 [‐30.70, 42.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Simultaneous versus fixed delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.0 [‐30.41, 8.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NMES (simultaneous frequencies) versus control NMES (sequential or fixed frequencies)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011289.pub2/references#CD011289-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011289.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011289-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011289-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011289-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="pt#CD011289-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011289-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011289\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011289\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011289\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011289\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011289\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011289.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011289.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011289.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011289.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011289.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714190337"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011289.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714190341"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011289.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d68a30c4b937d',t:'MTc0MDcxNDE5MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 